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RESEARCH ARTICLE Open Access
Transcriptome analyses of liver in newly-
hatched chicks during the metabolic
perturbation of fasting and re-feeding
reveals THRSPA as the key lipogenic
transcription factor
Larry A. Cogburn1* , Nares Trakooljul1,2, Xiaofei Wang3, Laura E. Ellestad4,5 and Tom E. Porter5
Abstract
Background: The fasting-refeeding perturbation has been used extensively to reveal specific genes and metabolic
pathways that control energy metabolism in the chicken. Most global transcriptional scans of the fasting-refeeding
response in liver have focused on juvenile chickens that were 1, 2 or 4 weeks old. The present study was aimed at
the immediate post-hatch period, in which newly-hatched chicks were subjected to fasting for 4, 24 or 48 h, then
refed for 4, 24 or 48 h, and compared with a fully-fed control group at each age (D1-D4).
Results: Visual analysis of hepatic gene expression profiles using hierarchical and K-means clustering showed two
distinct patterns, genes with higher expression during fasting and depressed expression upon refeeding and those
with an opposing pattern of expression, which exhibit very low expression during fasting and more abundant
expression with refeeding. Differentially-expressed genes (DEGs), identified from five prominent pair-wise contrasts
of fed, fasted and refed conditions, were subjected to Ingenuity Pathway Analysis. This enabled mapping of
analysis-ready (AR)-DEGs to canonical and metabolic pathways controlled by distinct gene interaction networks. The
largest number of hepatic DEGs was identified by two contrasts: D2FED48h/D2FAST48h (968 genes) and
D2FAST48h/D3REFED24h (1198 genes). The major genes acutely depressed by fasting and elevated upon refeeding
included ANGTPL, ATPCL, DIO2, FASN, ME1, SCD, PPARG, SREBP2 and THRSPA—a primary lipogenic transcription factor.
In contrast, major lipolytic genes were up-regulated by fasting or down-regulated after refeeding, including ALDOB,
IL-15, LDHB, LPIN2, NFE2L2, NR3C1, NR0B1, PANK1, PPARA, SERTAD2 and UPP2.
Conclusions: Transcriptional profiling of liver during fasting/re-feeding of newly-hatched chicks revealed several highly-
expressed upstream regulators, which enable the metabolic switch from fasted (lipolytic/gluconeogenic) to fed or refed
(lipogenic/thermogenic) states. This rapid homeorhetic shift of whole-body metabolism from a catabolic-fasting state to an
anabolic-fed state appears precisely orchestrated by a small number of ligand-activated transcription factors that provide
either a fasting-lipolytic state (PPARA, NR3C1, NFE2L2, SERTAD2, FOX01, NR0B1, RXR) or a fully-fed and refed lipogenic/
thermogenic state (THRSPA, SREBF2, PPARG, PPARD, JUN, ATF3, CTNNB1). THRSPA has emerged as the key transcriptional
regulator that drives lipogenesis and thermogenesis in hatchling chicks, as shown here in fed and re-fed states.
Keywords: Up-stream regulators, Target genes, Lipid metabolism, Lipolysis, Lipogenesis, Thermogenesis, Gene interaction
networks, Homeorhesis, Spot 14 (THRSPA), THRSP paralogs, Metabolic switch, ying-yang metabolic regulation, Reciprocal
inhibition/activation
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Background
The first few days after hatching pose the most critical
period in the chicken’s terrestrial life. Upon hatching, the
chick must sharply increase its metabolic rate to achieve
and maintain an exceptionally high core temperature (41–
42 °C) for life. The hatchling chick emerges from the egg
shell with a retracted yolk sac, a lipid-drenched gut, and a
lipid-laden liver that ensures its survival for two or 3 days,
even without feeding. After consuming its first meal, the
hatchling chick launches a predominant lipogenic drive in
its major metabolic organ—the liver.
We have developed functional genomic tools and gen-
etic resources to gain a global view and more detailed
understanding of genes and gene interaction networks
that regulate important biological processes (e.g.,
growth, metabolism and development) in the chicken
[1–4]. Using our original chicken (3.2 K) liver cDNA
microarray, we explored time-course transcriptional pro-
files in liver of chickens during the embryo-to-hatching
transition and high-growth (HG) and low-growth (LG)
chickens during fasting and refeeding [1, 3, 4]. The tran-
scriptional analysis of liver in late embryos and newly
hatched chicks revealed two distinct gene expression
patterns. Cluster “A” genes were highly expressed in late
embryos (e16-e20) and depressed in hatchlings (d1-d9).
In contrast, Cluster “B” genes were low in late embryos
and sharply elevated after hatching. In a second study
using the 3.2 K liver array, we examined transcriptional
profiles in HG and LG chickens during an episode of
fasting and refeeding at 6wk. Furthermore, we discov-
ered several clusters of functionally-related hepatic genes
that respond to the abrupt metabolic perturbation of the
embryo-to-hatchling transition or fasting and refeeding.
These clusters of differentially-expressed genes (DEGs)
were composed of several transcription factors (THRSPA,
PPARA, PPARG, and SREBF1), growth factors (IGF1,
ATRN), metabolic enzymes (FASN, SCD, ME and PCK1)
and transport proteins (FABP1, IGFBP4). Recently, we
used the Affymetrix Chicken Genome Chip® to expand
the repertoire of hepatic genes involved in the homeorhe-
tic regulation of metabolism during the peri-hatch period
[5]. Our study provided a higher resolution of transcrip-
tional responses during the switch from ectothermic (em-
bryo) to endothermic (hatchling) metabolism. We also
confirmed and expanded the number DEGs that populate
two distinct clusters of hepatic genes with opposing ex-
pression patterns, which we originally reported with our
low-density 3.2 K liver array [1, 3]. Thus, THRSPA has
emerged as the major transcription factor and highest-
expressed hepatic gene supporting enhanced lipogenesis
and thermogenesis in newly-hatched chicks [5]. The tran-
scriptional choreography of the abrupt switch from lipoly-
sis in late embryos to lipogenesis/thermogenesis in
hatchling chicks appears to be controlled by about 30
microRNAs (miRNAs), which selectively target major
hepatic transcription factors and their downstream meta-
bolic genes [6]. Further, this RNA sequencing of liver has
revealed reciprocal expression patterns of numerous miR-
NAs and their metabolic gene targets during the embryo-
to-hatchling transition.
The fasting-refeeding perturbation has been used ex-
tensively to uncover specific genes and pathways that
control energy metabolism in chickens of various ages.
For example, the transcriptional analysis of liver in 4-
wk-old broiler chickens fasted for either 16 or 48 h re-
vealed four hierarchical clusters of functionally related
genes, where the majority of metabolic DEGs were down-
regulated by prolonged fasting [7]. Compared to the con-
trol (fed) group, hepatic genes controlling β-oxidation of
fatty acids, gluconeogenesis and ketogenesis were up-
regulated by fasting, while genes involved in fatty acid and
cholesterol biosynthesis were highly expressed in fed birds,
with the notable exception of HMG-CoA synthase 1
(HMGCS1), which was up-regulated by prolonged fasting
of 4wk broiler chickens. Earlier, we used a chicken 20.7 K
oligo microarray for transcriptome profiling of the hypo-
thalamus in broiler chicks during an episode of fasting
and refeeding immediately post-hatching, D0-D4 [8]. This
transcriptional study of the hypothalamus demonstrates
the importance of the neuropeptide Y and melanocortin
pathways in regulation of metabolic and regulatory re-
sponses to fasting and refeeding in newly-hatched chicks.
A subsequent microarray analysis of the hypothalamus in
2wk broiler chickens, which were fasted for 24 h or 48 h,
or fasted for 48 h, then refed for 24 h [9], confirmed our
original report of opposing actions of hypothalamic orexi-
genic and anorexigenic pathways in the switch from glu-
cose metabolism in fed (and refed) chicks to lipid
catabolism of chickens fasted for either 24 h or 48 h [8].
Our immediate interest in the present study was
examination of global patterns of hepatic gene expres-
sion in newly-hatched cockerels during a fasting-
refeeding perturbation, given during the first 4 days (D0-
D4) of terrestrial life. The first few days after hatching
and the associated shift from metabolism of stored yolk
to metabolism of ingested feed are critical for normal
growth of the chicks. Failure to adequately make this
shift can result in failure of the chicks to thrive and
grow. Additionally, the time from hatching to provision
of feed can vary in the poultry industry, due to timing of
the hatch and distance for transportation of hatchling
chicks to the rearing houses. However, relatively little is
known about the mechanisms controlling the metabolic
switch from lipolytic/gluconeogenic to lipogenic/glyco-
lytic metabolism associated with initial feeding of newly
hatched chicks. Previous studies of gene expression in
regulatory and metabolic tissues during a bout of fasting
and refeeding in the chicken have been implemented
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after chickens were weeks old (1, 2, 4 or 6 wk), well after
depletion of residual yolk lipids and after metabolic and
regulatory pathways are well established. An exception
was the study of transcriptional regulation of hepatic
lipogenesis in unfed hatched broiler chicks versus seven-
day-old chicks by microarray analysis coupled with tar-
geted qRT-PCR analysis of liver from one-wk-old chicks,
which were withheld from feed for the first 48 h after
hatching [10]. Delayed feeding of these hatchling chicks
depressed the up-regulation of key lipogenic transcrip-
tion factors (THRSPA, SREBF1, SREBF2 and PPARG)
and metabolic enzymes (SCD, ME1, FASN, ACACA and
ACLY), which were normally induced with initial feed-
ing. A recent study investigating the impact of delayed
feeding at hatch on gene expression patterns in liver and
breast muscle revealed perturbations in developmental
profiles of PPARG and CHREBP, which indicates a tran-
sitional delay in the switch from lipid to carbohydrate
metabolism in these tissues [11].
A chicken 20.7 K oligo microarray was used to examine
hepatic transcriptomes of fasting (4, 24 and 48 h), refeed-
ing (4, 24 and 48 h) and fully-fed (D1-D4) broiler chicks
using the same experimental design described previously
for transcriptional analysis of the hypothalamus in newly-
hatched chicks during fasting and refeeding [8]. Pairwise
comparisons of 10 treatment groups allowed identifi-
cation of hundreds of differentially expressed genes
(DEGs), including major transcription factors and
their direct down-stream targets, which control lipid
metabolism via gene interaction networks that control
metabolic and regulatory pathways during the first 4 days
post-hatching (D0-D4). Our analysis has identified several
major transcription factors and their coactivators and co-
inhibitors that govern ying-yang regulation of the switch




The metabolic response of newly-hatched (D0-D4) chicks
to the fasting and re-feeding perturbation was evaluated
by several physiological (phenotypic) measurements dur-
ing after hatching, including body weight (Fig. 1a), plasma
glucose (Fig. 1b), triglycerides (Fig. 1c) and non-esterified
fatty acids (NEFA; Fig. 1d). Analysis of variance (ANOVA)
showed significant (P ≤ 0.0001) main effects of treatment
(T) and age (A) and the interaction of T x A (P ≤ 0.001)
for body weight. At hatching (Day 0; D0), the average
Fig. 1 Body weight (a) and plasma metabolite [glucose (b), triglycerides (c) and (d) non-esterified fatty acids (NEFA)] responses of hatchling
chicks. Each value represents the least square mean (LSM) and error (LSE) of five cockerels. The first three data points represent fasting treatment
levels (D0FAST4h; D1FAST24h and D2FAST48h), while the last three data points (shaded area) represent refeeding treatment levels (D2REFED4h,
D3REFED24h and D4REFED48h). The analysis of variance (ANOVA), using Type III error, indicates overall level of significance (*P ≤ 0.05; ***P ≤
0.0001) for the main effects of fasting-refeeding treatments (T) and age (A), and their interaction (T x A) [shown in shaded area]. A single asterisk,
below or above treatment points, indicates a significant difference (P ≤ 0.05) for each pairwise contrast between a fully-fed (FED) control group
and a fasting-refeeding treatment. Note that the D2FED control group was used for both the D2FAST48h and D2REFED4h contrast
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body weight (BW) was 46 g (Fig. 1a). On the last day of
treatment (D4), the BW of the fully-fed group (D4FED96h
or T9) was almost 2-fold higher than the D0FAST4h (T1)
group at hatching. The BW of chicks fasted for 48 h
(D2FAST48h or T5) was only 70% of the fully-fed group
(D2FED48h or T4). And likewise, the BW of the chicks
refed for 48 h (D4REFED48h or T10) was 23% lower than
that of the fully-fed group on Day 4 (D4FED96h).
Plasma glucose levels showed a main effect of treatment
and a T x A interaction (P ≤ 0.0001). Glycemia differed
among treatment groups on Day 2, where fed chicks
(D2FED48h) had higher (P ≤ 0.05) levels of circulating glu-
cose than D2FAST48h or D2REFED4h (T6) chicks (Fig.
1b). Plasma glucose was similar for Day 3 and Day 4 treat-
ment groups (375mg/dL), which was within the normal
glycemia range for the chicken. Plasma triglyceride levels
(Fig. 1c) were dramatically depressed (P ≤ 0.05) in chicks
fasted for 4, 24 or 48 h (an average level of 54.9mg/dL)
when compared to that (120.9mg/dL) of fully-fed chicks
(D1FED24h or T2; and D2FED48h or T4). Circulating tri-
glycerides levels of refed groups (D3REFED24h or T8; and
D4REFED48h or T10) were lower than their respective
fully-fed control groups (D3FED72h or T7; and D4FED96h
or T9). Plasma NEFA levels were elevated (P ≤ 0.05) in
fasted chicks (D0FAST4h; D1FAST24h; and D2FAST48h)
when compared to fed chicks (D1FED24h and D2FED48h)
(Fig. 1c). Plasma NEFA levels of fasted chicks at 4 h after
refeeding (D2REFED4h) were lower (P ≤ 0.05) than fully-
fed chickens (D2FED24h) (Fig. 1d). However, plasma NEFA
levels in the D3REFED24h and D4REFED48h chicks were
similar to their respective control fed groups (D3FED72h;
and D4FED96h).
Preliminary visual analysis of DEGs using GeneSpring GX
software
Preliminary Venn diagram
First, we used GeneSpring GX software with default set-
tings to determine the number of DEGs for three inclu-
sive treatment groups: FAST (4, 24, 48 h), FED (D1-D4)
and REFED (4, 24, 48 h). A Venn diagram (not shown)
revealed the distribution of these DEGs [FAST (1459
DEGs)), FED (243 DEGs) and REFED (1658 DEGs)], the
number of unique FAST (608 DEGs), FED (54 DEGs)
and REFED (794 DEGs) and the number of commonly-
shared genes (130 DEGs) and the number shared be-
tween FAST and REFED (698 DEGs). Clearly, the three
FAST (6-fold higher) and REFED (6.8-fold higher) con-
ditions provoked a greater number of DEGs than did the
four FED conditions.
Unsupervised hierarchical clustering and heat map
The heat map (Fig. 2a) generated by GeneSpring software
illustrates hierarchical clustering of 958 DEGs (FDR ad-
justed P ≤ 0.05) genes (Y-axis) across 10 treatment groups
(X-axis). Two major clusters of DEGs were identified,
where Cluster A represents about 52% of all DEGs, which
were sharply upregulated in all three fasted groups
(D0FAST4h, D1FAST24h and D2FAST48h) and down-
regulated in both the fully-fed groups (D3FED48h and
D4FED96h) and the re-fed groups (D3REFED24h and
D4REFED48h). In contrast, the expression of the other
half of all DEGs was down-regulated by prolonged fasting
for either 24 or 48 h (Cluster B). With the exception of the
D0FAST4h and D1FED24h groups, treatment clusters
show that the expression of genes in Cluster A was
down-regulated in fully-fed groups (D2FED, D3FED
and D4FED) and refed groups (D3REFED24h and
D4REFED48h). Likewise, the DEGs in Cluster B were
highly expressed in fed and refed groups on D3 and
D4 of treatment. The majority of DEGs in the D1FED
and D2REFED4h treatment groups were also highly
expressed and clustered together in the condition
(treatment) tree. This dataset from unsupervised hier-
archical clustering was only used for preliminary vis-
ual analysis of gene expression patterns.
K-means cluster analysis
A more stringent statistical analysis, afforded by K-means
clustering, was used to identify clusters of functionally-
related DEGs. Four pairwise contrasts were used to visually
identify DEGs that responded to fasting (D1FAST24h and
D2FAST48h) or refeeding (D2REFED4h and D3REFED24h).
The K-means cluster analysis identified 196 DEGs (FDR ad-
justed P ≤ 0.05), which form 10 clusters (Cluster 0–9) of
functionally-related DEGs (Additional file 1). Plots of eight
K-means clusters (Fig. 2b) provide a detailed view of two
distinct gene expression patterns, while two additional K-
means clusters of lipogenic genes with low amplitude re-
sponses were not presented in this figure. Four clusters had
low expression during fasting (24 h or 48 h), and a sharp
log-scale increase in abundance was found at 4 h or 24 h
after refeeding (e.g., THRSPA, ME1, SCD, DIO2, and
PLIN2). In contrast, fasting for 24 h or 48 h increased ex-
pression of four gene clusters, while refeeding (4 h or 24 h)
reduced hepatic expression, albeit at lower amplitude (e.g.,
ACAA1, IGFBP2, LPIN2, SIRT5 and UPP2). The genes
found in Clusters 1, 2, 5 and 6 (Fig. 2b) were down-
regulated by fasting and upregulated by refeeding after a 48
h fast. These lipogenic genes are involved in energy metab-
olism and synthesis of fatty acids. For example, Cluster 5
represents the two most abundant DEGs: thyroid hormone
responsive Spot 14 protein alpha (THRSPA), a major lipo-
genic transcription factor, and malic enzyme (ME1), a key
enzyme controlling fat biosynthesis; expression of both
genes was depressed by fasting and sharply rebound after
refeeding. Three additional clusters of lipogenic DEGs (Clus-
ters 1, 2 and 6) have identical expression patterns, with high-
est expression in the refed state. In contrast, the lipolytic
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DEGs found in Clusters 0, 3, 7, and 9 were upregulated by
fasting and down-regulated upon refeeding. Many of these
genes are involved in fat catabolism and acute phase re-
sponses (ACAA1, HMGCL, HMGCS1, LDHB, LPIN2, SIRT3
and SIRT5). Annotated lists and plots of DEGs assigned to
all 10 K-means clusters are provided in Additional file 1.
Comparison of DEGs identified by microarray analysis vs.
“analysis ready” (AR)-DEGs used for ingenuity pathway
analysis (IPA)
The microarray DEGs that mapped to known mamma-
lian genes accrued in the Ingenuity Knowledge Base
were considered as AR-DEGs by IPA. However, almost
one-quarter of the chicken-specific DEGs determined
from our microarray analysis were rejected by IPA due
to the absence of a valid Entrez Gene ID accrued in the
mammalian-centric Ingenuity Knowledge Base (Add-
itional file 2). Chicken transcripts possessing a genomic
locus prefix (LOC) ID number or an avian-specific gene
ID were largely rejected by IPA. This difference between
microarray DEGs and the reduced number of AR-DEGs
accepted by IPA for functional analysis of chicken genes
could also be attributed to a large number of un-
annotated oligo probes (23%) found on the chicken 20.7
K oligo array, which was last annotated in 2009 [12].
The numbers of up-regulated and down-regulated AR-
DEGs for seven contrasts are presented in a stacked bar
graph (Fig. 3a). Fewer AR-DEGs were found in the
D0FAST4h vs. D1FED24h contrast (189 AR-DEGs) and
D1FED24h vs. D1FAST24h contrast (259 AR-DEGs). The
greatest number of AR-DEGs was found in the D2FED48h
vs. D2FAST48h (968 AR-DEGs) and D2 FAST48h vs.
Fig. 2 Initial hierarchical clustering analysis of differentially-expressed genes (DEGs) (P≤ 0.05) identified in liver of newly-hatchling chicks during
the fasting-refeeding perturbation (Panel a). This heat map, representing two-way hierarchical clustering of 1170 DEGs (Y-axis) across 10 treatment
groups (X-axis), shows two major clusters of DE genes that are either up-regulated (Cluster A) or down-regulated (Cluster B) by fasting (4, 24 and
48 h) after hatch. In contrast, Cluster A genes are down-regulated in the fully-fed (FED) and refed (REFED) groups on day 3(D3) and D4, whereas
Cluster B genes are up-regulated after refeeding and in FED groups on D2, D3 and D4. Panel b. K-means cluster plots of DEGs (log2 FC) identified
in four contrasts of fasting [C1 = D1FED vs. D1FAST24h; and C2 = D2FED vs. D2FAST48h) and refeeding (C3 = D2FAST48h vs. D3REFED4h; and
C4 = D2FAST48 vs. D3REFED24h). K-means analysis revealed two distinct gene expression patterns, each composed of four clusters of DEGs
identified by microarray and statistical analysis. Four distinct K-means clusters of lipogenic genes were down-regulated by fasting and sharply
rebounded at 4 h or 24 h after refeeding. In contrast, four other clusters represent lipolytic genes whose expression was up-regulated by fasting
and sharply down-regulated after refeeding. The original responses showed positive or negative log2 FC values which represent down-regulation
or up-regulation by fasting, respectively. Further, positive or negative log2 FC means indicates either down-regulation or up-regulation caused by
re-feeding for either 4 h or 24 h after a 48 h fast, respectively. However, the log2 FC values shown here were multiplied by − 1 to make the
relative expression (log2 fold-change) either positive for up-regulation or negative for down-regulation of gene expression. Several examples of
major metabolic DEGs are provided for each cluster. An annotated list of DEGs identified in each K-means cluster is provided in Additional file 1,
which also includes a composite graph of all K-means clusters including the low-amplitude changes in Clusters 4 and 8, both of which were
down-regulated with fasting and sharply up-regulated with refeeding
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D3REFED24h (1198 AR-DEGs) contrasts. The Venn
diagram in Fig. 3b shows the three-way comparison of
D0FAST4h vs. D1FED24h, D1FED24h vs. D1FAST24h,
and D2FED48h vs. D2FAST48h contrasts. The largest
number of unique DEGs (750 AR-DEGs) was found in
the D2FED48h vs. D2FAST48h, while only 58 AR-
DEGs were commonly shared among the three contrasts.
The second Venn diagram (Fig. 3c) compared the number
of AR-DEGs found in three fasting-refeeding con-
trasts: D2FAST48h vs. D2REFED4h, D3REFED24h or
D4REFED48h. The largest number of unique genes
(489 AR-DEGs) was found in the D2FAST48h vs.
D2REFED24h, while 303 AR-DEGs were commonly-
shared among all three fasting-refeeding contrasts.
Annotated lists of the AR-DEGs from five meaning-
ful contrasts, which were used for IPA, are presented
in Additional file 3.
IPA of five prominent pairwise contrasts during a fasting-
refeeding perturbation (D1-D4)
Effects of 24 h fasting (D1FED24h vs. D1FAST24h contrast)
A summary of IPA of liver transcriptomes from the
D1FED24h vs. D1FAST24h contrast is presented in Table 1.
The top canonical pathways overpopulated by AR-DEGs
from this contrast were related to tryptophan degradation
and biosynthesis of cholesterol and nicotinamide adenine
dinucleotide (NAD). The top three upstream regulators
identified by IPA in the D1FED24h vs. D1FAST24h con-
trast were SREBF2, PPARA and SREBF1. The most highly
represented subcategories under the IPA “Molecular and
Cellular Functions” category were “Small Molecule Bio-
chemistry” (94 AR-DEGs), “Lipid Metabolism” (66 AR-
DEGs) and “Molecular Transport” (68 AR-DEGs). The
“Physiological System Development and Function’ category
in IPA contained the subcategories: “Connective Tis-
sue Development and Function” (26 AR-DEGs), “Di-
gestive System Development and Function” (17 AR-
DEGs), “Hepatic System Development and Function”
(17 AR-DEGs), “Organ Morphology” (21 AR-DEGs)
and “Organismal Development (19 AR-DEGs)”. Among
the most highly expressed up-regulated genes in the
D1FED24h treatment were THRSPA, deiodinase 2 (DIO2),
ME1 and PLIN2. The top down-regulated genes (negative
log2 ratios) in the D1FAST24h liver were uridine phos-
phorylase 2 (UPP2), cytochrome P450 family 4 subfamily
A member 22 (CYP4A22), 3-hydroxy-3-methylglutaryl-
CoA synthase 1 (HMGCS1) and cytochrome P450, family
2, subfamily c, polypeptide 44 (CYP2C44).
The gene network depicted in Fig. 4a was centered on
the interaction of three transcription factors: catenin
beta 1 (CTNNB1), activating transcription factor 4
[ATF4; or cAMP-response element binding protein 2
Fig. 3 Stacked-bar graph of seven pairwise treatment contrasts showing the highest numbers of up-regulated and down-regulated “Analysis
Ready” (AR)-DEGs among the 45 possible pairwise contrasts of 10 treatment conditions (Panel a). The Venn diagrams provide the numbers of
unique and commonly shared AR-DEGs found within the meaningful contrasts. The Venn diagram in Panel b compared three contrasts of AR-
DEGs in chicks that were either fasted for 4 h immediately after hatching (D0FAST4h), fasted for 24 h (D1FAST24h) or fasted for 48 h (D2FAST48h)
versus chicks that were either fully-fed for 24 h (D1FED24h) or 48 h (D2FED48h). Likewise, the recovery from prolonged fasting (D2FAST48h) was
examined by three refeeding contrasts (D2REFED4h, D3REFED24h or D4REFED48h) (Panel c). The number of AR-DEGs found in each contrast is
shown in brackets, while numbers within arcs represents genes shared between or among contrasts. Annotated lists of AR-DEGs found in the five
contrasts are provided by multiple worksheets in Additional file 3
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(CREB2)] and SERTA domain containing 2 (SERTAD2),
which is a newly discovered co-regulator of lipolysis,
thermogenesis and oxidative metabolism. SERTAD2 has
a direct action on both DIO2 and acyl-CoA oxidase 1
(ACOX1), which is the initial enzyme in the fatty acid β-
oxidation pathway. This network was functionally anno-
tated by IPA as “Lipid Metabolism” and “Molecular
Transport”. Several lipogenic genes in this network are
highly expressed in liver of the D1FED24h chicks,
including ME1, SCD, FADS2, CYP51A1, PLIN2, INSIG1,
DIO2 and basic leucine zipper ATF-like transcription fac-
tor 3 (BATF3), a transcriptional repressor of the JUN
oncogene. The cationic amino acid transporter (SLC7A3),
a known target of ATF4, was slightly upregulated in the
D1FED24h chicks as well as phosphoglycerate kinase 1
(PGK1), a glycolytic enzyme and direct target of CREB.
Several additional genes were expressed higher in the
D1FAST24h treatment, including PSAT1, CTH, LDHB,
Table 1 IPA summary of liver transcriptomes in-hatchling chicks--D1FED24h vs. D1FAST24h contrast
Top Canonical Pathways p-value Overlap Ratio
Tryptophan Degradation (Eukaryotic) 1.15E-12 42.9% 9/21
Super-pathway of Cholesterol Biosynthesis 9.65E-10 28.6% 8/28
Cholesterol Biosynthesis I-III 4.48E-09 46.2% 6/13
NAD Biosynthesis II 9.23E-09 40.0% 6/15
Tryptophan Degradation 2-amino-3-carboxymuconate 9.83E-09 62.5% 5/8






Top Molecular and Cellular Functions p-value # Genes
Amino Acid Metabolism 9.80E-03 - 6.26E-11 25
Small Molecule Biochemistry 1.19–02 - 6.26E-11 94
Lipid Metabolism 1.19–02 - 2.16E-08 66
Molecular Transport 1.19–02 - 2.16E-08 68
Vitamin and Mineral Metabolism 5.45E-03 - 7.14E-07 21
Physiological System Development and Function p-value # Genes
Connective Tissue Development and Function 1.13E-02 - 3.88E-04 26
Digestive System Development and Function 1.02E-02 - 4.29E-04 17
Hepatic System Development and Function 6.03E-03 - 4.29E-04 17
Organ Morphology 1.13E-02 - 4.29E-04 21
Organismal Development 1.13E-02 - 4.29E-04 19
Top Up-regulated genes D1FED24h/D1FAST24h Top Down-regulated genes D1FED24h/D1FAST24h
THRSPA 4.46 UPP2 −2.70
DIO2 3.24 CYP4A22 −2.01
HKDC1 3.22 HMGCS1 −1.89
ME1 2.75 CYP3A7 −1.73
PLIN2 2.63 TDH −1.62
FADS2 2.47 FKBP5 −1.62
MSMO1 2.21 ADSL −1.60
CYP51A1 2.06 ECI2 −1.52
SCD 1.74 CYP2C44 −1.44
BATF3 1.72 LDHB −1.37
Ingenuity Pathway Analysis (IPA) was used for functional analysis of 259 DEGs (FDR adj. P ≤ 0.05) that were also “Analysis Ready” (AR)-DEGs from the D1FED24h vs.
D1FAST24h contrast. The top 10 up-regulated and down-regulated AR-DEGs are presented along with their respective log2 ratio of treatment conditions
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IGFBP2, LY6E, EPCAM, SESN1 and three monoxygenases
(CYB5A, CYP3A4 and CYP3A7). The Ingenuity Upstream
Regulator Analysis identified 15 direct targets of CTNNB1
(Fig. 4b), 7 up-regulated and 8 down-regulated AR-DEGs.
Ingenuity predicts that CTNNB1 should be inhibited (blue
symbol), which would lead to inhibition (blue arrows) of
five direct target genes [epidermal growth factor receptor
(EGFR), epithelial cell adhesion molecule (EPCAM), EPH
receptor B2 (EPHB2) and sestrin 1 (SESN1)]. Ingenuity
also predicts that ATF4 would be activated, which would
lead to the activation of three direct target genes
(CTNNB1, HSPA5 and SLC7A3) as indicated by the
orange-colored arrows.
Effects of 48 h fasting [D2FED48h vs. D2FAST48h contrast]
The summary of the Ingenuity Pathway Analysis of liver
transcriptomes from the D2FED48h vs. D2FAST48h
contrast is presented in Table 2. The major canonical
pathways populated by AR-DEGs in this contrast were
related to cholesterol biosynthesis, protein ubiquitina-
tion, tryptophan degradation and the oxidative stress re-
sponse. The top transcription factors found in this
contrast were hepatocyte nuclear factor 4 alpha
(HNF4A), peroxisome proliferator activated receptor
alpha (PPARA), tumor protein p53 (TP53), nuclear fac-
tor, erythroid 2 like 2 (NFE2L2) and MYC proto-
oncogene, bHLH transcription factor (MYC). The top
IPA “Molecular and Cellular Functions” were “Lipid Me-
tabolism” (195 AR-DEGs), “Small Molecule Biochemis-
try” (277 AR-DEGs) and “Cell Cycle” (175 AR-DEGs).
Tissue morphology, tissue (connective) development,
and organismal survival and development were the most
populated subcategories in “Physiological System Devel-
opment and Function” category of IPA. The top four
up-regulated AR-DEGs in the D2FED48h vs.
D2FAST48h contrast were THRSPA, ME1, SCD, and
FADS2, while the highest expressed AR-DEGs in the
D2FAST48h treatment were IGFBP2, adenylosuccinate
lyase (ADSL), CYP3A7, and CYP4A22.
Additional file 4 provides annotated lists of AR-DEGs
assigned by IPA to canonical pathways and biological pro-
cesses, which were over-represented by the D2FED48h vs.
D2FAST48h contrast (see Table 2). For example, IPA rec-
ognized 36 AR-DEGs that were involved in “Disorders of
Lipid Metabolism”, where 14 AR-DEGs were more highly
expressed in the D2FED48h group and 22 AR-DEGs had
greater expression in the D2FAST48h chicks. The import-
ance of “Oxidation of Fatty Acids” was confirmed by the
greater abundance of 24 AR-DEGs in D2FAST48h chicks,
whereas only 4 AR-DEGs were higher in the D2FED48h
treatment. Likewise, the IPA canonical pathway “LPS/IL1
Inhibition of RXR Function” had 18 AR-DEGs that were
more abundant in the D2FAST48h group, compared to
only 8 genes with higher expression in the D2FED48h
chicks. Another canonical pathway in IPA “NRF2-Medi-
ated Oxidative Stress” was represented by 12 up-regulated
and 14 down-regulated AR-DEGs from this contrast.
Under the “LXR/RXR Activation” pathway, only 6 AR-
DEGs were up-regulated, while 12 AR-DEGs were more
abundant in the D2FAST48h treatment. Similarly, the
“FXR/RXR Activation” pathway was recognized by 4 up-
regulated and 10 down-regulated AR-DEGs. The “Coagu-
lation System” was more active in the D2FAST48h treat-
ment (7 AR-DEGs) than in the D2FED48h condition (1
AR-DEG).
The subcellular distribution of 107 AR-DEGs that
regulate “Synthesis of Lipid” in liver of chicks from the
D2FED48h vs. D2FAST48h contrast is presented in
Fig. 5. In this overview of lipid synthesis, AR-DEGs with
red symbols are lipogenic genes, which are highly
expressed in liver of D2FED48h chicks, whereas green
symbols indicate greater abundance of lipolytic genes in
the D2FAST48h treatment (Additional file 4). This sub-
cellular distribution of 54 up-regulated and 53 down-
regulated AR-DEGs clearly illustrates transcription con-
trol of lipid synthesis by five transcription factors
(THRSPA, NR3C1, CTNNB1, NROB1 and CRY1), which
control expression of numerous downstream target
genes. Most AR-DEGs were found in the cytoplasm (70
AR-DEGs, which are mainly metabolic enzymes, trans-
porters, kinases and phosphatases) with fewer genes in
the plasma membrane (15 AR-DEGs; receptors, trans-
porters, enzymes, a peptidase and a kinase) and extracel-
lular space (17 AR-DEGs; coagulation factors, cytokines,
transporters and an enzyme).
Effects of 4 h re-feeding [D2FAST48h vs. D2REFED4h
contrast]
The IPA summary of liver transcriptomes in the
D2FAST48h vs. D2REFED4h contrast is presented in
(See figure on previous page.)
Fig. 4 A gene interaction network (Panel a) of lipogenic (green symbols) and lipolytic (red symbols) AR-DEGS found in the D1FED24h vs.
D1FAST24h contrast. This gene network was functionally annotated by IPA as “Lipid Metabolism/Molecular Transport”. These genes are
differentially regulated by two transcription factors [catenin beta 1 (CTNNB1) and activating transcription factor 4 (ATF4)]. Ingenuity® Upstream
Regulator Analysis identified additional direct targets for each transcription factor (Panel b) and predicts that CTNNB1 should be inhibited due to
down-regulation of its eight direct target genes (EGFR, EPCAM, EPHB2, IGFBP2, IRF8, LY6E, SESN1 and CYB5A), although the expression of CTNNB1
and seven direct target genes were up-regulated (i.e., higher in D1FED24h). Ingenuity correctly predicted activation of ATF4 and up-regulation of
four direct target genes including CTNNB1 and another transcription factor, Jun proto-oncogene, AP-1 transcription factor subunit (JUN)
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Table 3. The top canonical pathways represented in this
contrast were related to cholesterol and zymosterol bio-
synthesis, protein ubiquitination and tryptophan degrad-
ation. The transcription factors and their respective
direct target genes identified by IPA were HNF4A,
PPARA, NFE2L2, TP53 and E2F transcription factor 1
(E2F1). “Cell Death and Survival”, “Lipid Metabolism”
and “Small Molecular Biochemistry” were among the
most represented “Molecular and Cellular Functions”
found in this contrast. The largest number of AR-DEGs
assigned to the “Physiological System Development and
Function” category of IPA was associated with connect-
ive tissue and morphology of tissue. Among the highest
expressed genes in the D2FAST48h treatment were
CYP4A22, UPP2, IGFBP2, and N-myc downstream regu-
lated 1 (NDRG1), whereas THRSPA, hexokinase domain
Table 2 IPA summary of liver transcriptomes in hatchling chicks-D2FED48h vs. D2FAST48h contrast
Top Canonical Pathways p-value Overlap Ratio
Superpathway of Cholesterol Biosynthesis 1.36E-09 42.9% 12/28
Protein Ubiquitination Pathway 2.83E-08 13.3% 34/255
Tryptophan Degradation III (Eukaryotic) 1.65E-07 42.9% 9/21
NRF2-mediated Oxidative Stress Response 2.46E-07 14.4% 26/180
Cholesterol Biosynthesis I 5.92E-07 53.8% 7/13






Top Molecular and Cellular Functions p-value # Genes
Lipid Metabolism 1.83E-03 - 3.91E-15 195
Small Molecule Biochemistry 2.08E-03 - 3.91E-15 277
Cell Cycle 2.07E-03 - 1.26E-11 175
Amino Acid Metabolism 2.08E-03 - 4.78E-11 41
Cell Death and Survival 1.13E-03 - 5.19E-11 31
Physiological System Development and Function p-value # Genes
Tissue Morphology 2.00E-03 - 4.53E-06 92
Tissue Development 1.77E-03 - 9.24E-06 76
Connective Tissue Development and Function 2.00E-03 - 1.09E-05 116
Organismal Survival 2.13E-05 - 2.13E-05 200
Organismal Development 1.77E-03 - 4.61E-05 28
Top up-regulated genes D2FED48h/D2FAST48h Top down-regulated genes D2FED48h/D2FAST48h
THRSPA 6.19 IGFBP2 −3.45
ME1 4.74 ADSL −3.18
SCD 4.74 CYP3A7 −3.07
FADS2 3.63 CYP4A22 −2.74
LGALS2 3.47 CYP2C44 −2.66
CYP2C44 3.24 LDHB −2.62
PLIN2 3.23 UPP2 −2.48
MSMO1 2.49 EHHADH −2.41
ELOVL6 2.43 HADHB −2.31
INSIG1 2.33 BHMT −2.15
Ingenuity Pathway Analysis (IPA) was used for functional analysis of 968 Analysis Ready (AR)-DEGs from the D2FED48h vs. D2FAST48h contrast. The top 10 up-
regulated and down-regulated AR-DEGs are presented along with their respective log2 ratio of treatment conditions
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containing 1 (HKDC), cytochrome P450 family 51 sub-
family A member 1 (CYP51A1) and methylsterol mono-
oxygenase 1 (MSMO1) were the most abundant AR-
DEGs found in the D2REFED4h treatment.
The gene interaction network shown in Fig. 6a was
functionally annotated by IPA as “Lipid Metabolism”
and “Endocrine Function”. This network is centered on
the interactions of two transcription factors NR3C1 (or
GCR) and peroxisome proliferator activated receptor
delta (PPARD) with their direct target genes, three of
which are shared [major facilitator superfamily domain
containing 2A (MFSD2A), glutamate-ammonia ligase
(GLUL) and toll like receptor 5 (TLR5)]. Methionine
adenosyltransferase 1A (MAT1A) and tyrosine amino-
transferase (TAT) were the most abundant direct targets
of NR3C1, and were highly expressed in the D2FAST48h
treatment. Although PPARD and four of its target genes,
including angiopoietin like 3 (ANGPTL3) and acyl-CoA
synthetase long chain family member 5 (ACSL5), were
expressed more highly in the D2REFED4h treatment,
four other targets of PPARD [LPIN2, acyl-CoA oxidase 1
(ACOX1), SLC25A20 and ACSL1] were more highly
expressed in liver of the D2FAST48h chicks. Ingenuity
Upstream Regulator Analysis identified 38 AR-DEGs in
this contrast as direct targets of NR3C1 (Fig. 6b), 18
AR-DEGs were up-regulated and 20 AR-DEGs were
down-regulated in this contrast. Ingenuity predicted that
NR3C1 was activated (orange symbol), which would
lead to activation of four target AR-DEGs [FK506
binding protein 5 (FKBP5), hydroxysteroid 11-beta
Fig. 5 Subcellular distribution of 107 AR-DEGs functionally annotated by IPA as “Concentration of Lipids” from the D2FED48h vs. D2FAST48h
contrast. This figure provides an overview of the transcriptional hierarchy of hepatic genes that control the concentration of lipids. Genes with
red symbols are expressed higher in liver of D2FED48h cockerels, while green symbols indicate higher hepatic expression in the D2FAST48h
treatment. A group of five upstream regulators control transcription of numerous metabolic enzymes, transporters, kinases and phosphatases in
the cytoplasm, several transmembrane receptors, G-protein-coupled receptors, peptidases and enzymes in the plasma membrane, and even
fewer growth factors, transporters and enzymes found in extracellular space. IPA predicts that the concentration of lipid in liver would be
inhibited by the eight up-regulated transcription factors as indicated by the dashed blue lines, while yellow dashed lines represent inconsistence
between the expected state and observed state of downstream genes. An annotated list of these 107 AR-DEGs controlling concentration of lipid
is provided in Additional file 4
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dehydrogenase 1 (HSD11B1), interferon regulatory factor
8 (IRF8) and TAT] as shown by the orange arrows.
Ingenuity also identified 24 AR-DEGs as direct targets of
PPARD, which was predicted to be slightly activated
(orange symbol) since 8 of its direct targets were
up-regulated in this contrast as indicated by the orange
arrows. Ingenuity predicted inhibition of four target
AR-DEGs (ANGPTL3, CCND1, PCNA and THRSPA) as
depicted by the blunted blue lines.
Effects of 24 h re-feeding [D2FAST48h vs. D3REFED24h
contrast]
The IPA summary of liver transcriptomes in the
D2FAST48h vs. D3REFED24h contrast is presented in
Table 4. The major canonical pathways identified in this
contrast were related to tryptophan degradation, oxida-
tive stress response, cholesterol biosynthesis, protein
ubiquitination and oxidation of fatty acid. The top up-
stream regulators in this contrast were HNF4A, E2F1,
Table 3 IPA summary of liver transcriptomes in hatchling chicks–D2FAST48h vs. D2REFED4h contrast
Top Canonical Pathways p-value Overlap Ratio
Super-pathway of Cholesterol Biosynthesis 4.68E-09 35.7% 10/28 Cholesterol
Biosynthesis I-III 3.23E-08 53.8% 7/13
Protein Ubiquitination Pathway 9.27E-07 9.4% 24/255
Tryptophan Degradation III 5.12E-06 28.0% 7/25
Zymosterol Biosynthesis 1.01E-05 66.7% 4/6






Top Molecular and Cellular Functions p-value # Genes
Cell Death and Survival 7.95E-03 - 5.11E-10 206
Lipid Metabolism 7.07E-03 - 6.42E-09 118
Small Molecule Biochemistry 7.12E-03 - 6.42E-09 160
Vitamin and Mineral Metabolism 7.07E-03 - 4.29E-08 39
Cellular Growth and Proliferation 8.01E-03 - 7.35E-08 217
Physiological System Development and Function p-value # Genes
Reproductive System Development and Function 4.46E-05 - 4.46E-05 8
Connective Tissue Development and Function 7.76E-03 - 6.39E-05 89
Embryonic Development 5.24E-03 - 1.23E-04 29
Cardiovascular System Development and Function 5.24E-03 - 1.49E-04 10
Tissue Morphology 6.24E-03 - 1.99E-04 63
Top Up-regulated genes FAST48h/REFED4h Top Down-regulated genes FAST48h/REFED4h
CYP4A22 2.53 THRSPA −4.89
UPP2 2.49 HKDC1 −4.17
IGFBP2 1.79 CYP51A1 −3.60
NDRG1 1.77 MSMO1 −3.44
TDO2 1.68 PLIN2 −3.37
VSNL1 1.68 ME1 −2.78
HAL 1.56 UGP2 −2.72
TDH 1.53 AACS −2.68
CEPT1 1.51 ACSBG2 −2.50
SLC16A5 1.46 INSIG1 −2.43
Ingenuity Pathway Analysis (IPA) was used for functional analysis of 641 “Analysis Ready” (AR)-DEGs found in the D2FAST48h vs.D2REFED4h contrast. The top 10
up-regulated and down-regulated AR-DEGs are presented along with their respective log2 ratio of treatment conditions
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PPARA, NFE2L2 and E2F4. “Cell Death and Survival”
(434 AR-DEGs) and “Cell Cycle” (270 AR-DEGs) were
the most populated Molecular and Cellular Functions
identified by IPA. Under the “Physiological System De-
velopment and Function” category, 278 AR-DEGs were
assigned by IPA to the “Organismal Survival” subcat-
egory. The top up-regulated genes in this contrast in-
cluded IGFBP2, ADSL, LDHB and mannose binding
lectin 2 (MBL2), whereas THRSPA, ME1, SCD and
galectin 2 (LGALS2) were the highest expressed AR-
DEGs in the D3REFED24h treatment.
The gene network presented in Fig. 7a was function-
ally annotated by IPA as “Lipid Metabolism” and cen-
tered on interactions of SREBF2 and NFE2L2 with their
direct target AR-DEGs, including three shared genes
[THRSP(A), 7-dehydrocholesterol reductase (DHCR7)
and isocitrate dehydrogenase (NADP(+)) 1, cytosolic
(IDH1)]. Most direct targets of SREBF2 are lipogenic
and expressed at higher levels in liver of the
D3REFED24h chicks, including CYP51A, FASD2, SCD,
lanosterol synthase (LSS), NAD(P) dependent steroid
dehydrogenase-like (NSDHL), acetoacetyl-CoA synthe-
tase (AACS), THRSP, and DHCR7. However, five AR-
DEGs targets of SREBF2 are up-regulated genes (red
symbols) in this network, namely IDH1, cytochrome b5
type A (CYB5A), HMGCS1, retinoic acid receptor re-
sponder 2 (RARRES2; or chemerin, an adipokine) and
acetyl-CoA acyltransferase 2 (ACAA2), the enzyme that
catalyzes the final reaction in the fatty acid β-oxidation
pathway. In contrast, most direct targets of NFE2L2
were up-regulated by the D2FAST48h treatment, espe-
cially two very abundant target AR-DEGs [CYP4A22 and
betaine--homocysteine S-methyltransferase (BHMT)].
Ingenuity Upstream Regulator Analysis identified 22 dir-
ect targets of SREBF2 from this contrast (Fig. 7b), 6 AR-
DEGs were up-regulated, while 22 genes were down-
regulated or expressed higher in the D3REFED24h treat-
ment group. Ingenuity predicts that SREBF2 activity
should be inhibited, which would lead to inhibition of 15
direct target genes as indicated by the blue arrows.
Another gene network identified by IPA in the
D2FAST48h vs. D3REFED24h contrast focused on the
GCR (NR3C1) and was functionally annotated as “Nutri-
tional Disease” (Fig. 8a). The NR3C1 and all of its direct
target genes, except MFSD2A and PSMC3 interacting
protein (PSMC3IP), were expressed at higher levels in
liver of D2FAST48h chicks. Three direct targets of
NR3C1 [interleukin 1 receptor accessory protein
(IL1RAP), homocysteine inducible ER protein with ubi-
quitin like domain 1 (HERPUD1) and TLR5] interact
with components of the ILR1 complex [interleukin 1 re-
ceptor type 1 (IL1R1), interleukin 1 receptor like 1
(IL1RL1), single Ig and TIR domain containing (SIGIRR).
Another direct target gene, carboxypeptidase B2 (CPB2),
encodes the carboxypeptidase that inhibits fibrinolysis,
while promoting fibrinogenesis and the carboxypeptidase
N subunit 1 (CPN1) gene. Additional up-regulated direct
targets of NR3C1 include, selenoprotein P (SELENOP),
zinc fingers and homeoboxes 1 (ZHX1), IDH1, TAT,
SERTAD2, centromere protein V (CENPV), IL15, tyro-
sylprotein sulfotransferase 2 (TPST2), cell death-
inducing DFFA-like effector a (CIDEA; an activator of
apoptosis), and solute carrier family 25 member 33
(SLC25A33), which encodes the mitochondria pyrimi-
dine nucleotide transporter. Interestingly, two targets of
NR3C1 (SERTAD2 and CIDEA) in this network are im-
portant regulators of lipolysis and thermogenesis,
whereas the direct target of the TF SERTAD2,
phytanoyl-CoA 2-hydroxylase (PHYH), catalyzes the
alpha-oxidation of 3-methyl-branched fatty acids.
The second gene network (Fig. 8b) was annotated by
IPA as “Lipid Metabolism” and was centered on interac-
tions of the TF forkhead box O1 (FOXO1) with its 16
direct target genes. One up-regulted target gene, aldol-
ase, fructose-bisphosphate B (ALDOB), was linked to
components of vacuolar ATPase [ATPase H+ transport-
ing V1, subunit B2 (ATP6V1B2), subunit G1
(ATP6V1G1) and subunit E1 (ATP6V1E1)] and glutathi-
one transferase [microsomal glutathione S-transferase 3
(MGST3), glutathione S-transferase alpha 2 (GSTA2)
and hematopoietic prostaglandin D synthase (HPGDS)].
Six direct targets of FOXO1 were up-regulated in the
D2FAST48h vs. D3REFED24h contrast [glyoxylate and
hydroxypyruvate reductase (GRHPR), indoleamine 2,3-
dioxygenase 2 (IDO2), LPIN2, ALDOB, and SLC25A25],
while 10 AR-DEGs were expressed higher in liver of
D3REFED24h cockerels [ME1, mitochondrial ribosomal
protein S18A (MRPS18A), dendrocyte expressed seven
transmembrane protein (DCSTAMP), DIO2, solute car-
rier family 25 member 30 (SLC25A30), ELOVL fatty acid
(See figure on previous page.)
Fig. 6 This gene network, identified in the D2FAST48h vs. D2REFED4h contrast, shows interactions between two transcription factors [nuclear
receptor subfamily 3 group C member 1 (NR3C1) and peroxisome proliferator activated receptor delta (PPARD)] and their respective direct target
genes (Panel a). This network was functionally annotated by IPA as “Endocrine Function” and “Lipid Metabolism”. Ingenuity Upstream Analysis
predicts activation of NR3C1 (glucocorticoid receptor, GCR; Panel b), based on 18 up-regulated and 20 down-regulated AR-DEGs and slightly
activated PPARD, based on the up-regulated state of 12 direct targets (red gene symbols) compared to 11 down-regulated genes (green gene
symbols). Actually, the green gene symbols indicate higher expression in liver of D2REFED4h cockerels, while red gene symbols indicate higher
expression in the D2FAST48h treatment group
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elongase 6 (ELOVL6), ELOVL7, ELOVL5, transketolase
(TKT), and NDC80 kinetochore complex component
(SPC25). Five additional genes were indirectly related to
FOXO1 [dihydrolipoamide branched chain transacylase
E2 (DBT), ELOVL1, methionyl aminopeptidase 2
(METAP2), molybdenum cofactor sulfurase (MOCOS),
and ARP6 actin related protein 6 homolog (ACTR6)].
Additional file 5 provides annotated lists of AR-DEGs
assigned by IPA to canonical pathways and biological
processes over-represented by the D2FAST48h vs.
D3REFED24h contrast (see Table 4). An almost equal
number of transcription factors were up-regulated (9
AR-DEGs) or down-regulated (8 AR-DEGs) in this con-
trast. The major canonical pathways over-represented in
this contrast were “Protein Ubiquitination” (1 up-
regulated/36 downregulated), Nuclear Regulatory Factor
2 “(NRF2)-Mediated Oxidative Stress Response” (16 up-
regulated/17 downregulated), “Fatty Acid Metabolism”
Table 4 IPA summary of liver transcriptomes in hatcling chicks–D2FAST48h vs. D3REFED24h contrast
Top Canonical Pathways p-value Overlap Ratio
Tryptophan Degradation III 4.58E-12 56.0% 14/25
NRF2-mediated Oxidative Stress Response 4.30E-09 17.1% 33/193
Super-pathway of Cholesterol Biosynthesis 8.44E-09 42.9% 12/28
Protein Ubiquitination Pathway 1.42E-08 14.7% 39/265
Fatty Acid -oxidation I 5.11E-08 37.5% 12/32






Top Molecular and Cellular Functions p-value # Genes
Cell Death and Survival 3.73E-04 - 9.50E-20 434
Cell Cycle 3.58E-04 - 7.37E-18 270
Cellular Assembly and Organization 2.92E-04 - 6.25E-17 103
DNA Replication, Recombination, and Repair 3.58E-04 - 6.25E-17 176
Amino Acid Metabolism 2.69E-04 - 2.67E-12 38
Physiological System Development and Function p-value # Genes
Organismal Survival 6.21E-09 - 2.57E-09 278
Digestive System Development and Function 1.35E-04 - 1.47E-07 82
Hepatic System Development and Function 4.62E-05 - 1.47E-07 53
Organ Morphology 3.43E-05 - 1.47E-07 52
Organismal Development 4.62E-05 - 1.47E-07 65
Up-regulated genes FAST48h-REFED24h Down-regulated genes FAST48h-REFED24h
IGFBP2 3.19 THRSPA −5.99
ADSL 3.19 ME1 −4.84
LDHB 2.90 SCD −4.72
MBL2 2.85 LGALS2 −3.65
ALB 2.71 CYP51A1 −3.30
CYP4A22 2.66 PLIN2 −3.26
UPP2 2.61 FADS2 −3.24
BHMT 2.56 CDK1 −3.06
CYP3A7 2.40 RRM2 −3.03
NEFH 2.39 CDCA3 −2.93
Ingenuity Pathway Analysis (IPA) was used for functional analysis of 1198 “Analysis Ready” (AR)-DEGs from the D2FAST48h vs. D3REFED24h contrast. The top 10
up-regulated and down-regulated AR-DEGs are presented along with their respective log2 ratio of treatment conditions
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(26 up-regulated/3 downregulated), “Acute Phase Re-
sponse” (20 up-regulated/4 downregulated), “PPARA/
RXRA Activation” (13 up−/6 down-regulated), “LXR/
RXR Activation” (15 up−/3 down-regulated), “Fatty Acid
β-Activation” (11 up−/1 down-regulated), and “Coagula-
tion System” (8 up-regulated only).
Effects of re-feeding for 48 h [D2FAST48h vs. D4REFED48h
contrast]
The IPA summary of liver transcriptomes in the
D2FAST48h vs. D4REFED48h contrast is presented in
Table 5. The top canonical pathways identified in this
contrast were related to cholesterol biosynthesis, trypto-
phan degradation, sirtuin signaling, and inhibition of ret-
inoid X receptor (RXR) function. The top five upstream
regulators in this contrast were PPARA, NFE2L2,
HNF4A, SREBF2 and PPARG coactivator 1 alpha
(PPARGC1A), a major regulator of energy metabolism.
The major “Molecular and Cellular Functions” were
“Lipid Metabolism” (181 AR-DEGs), “Molecular Trans-
port” (190 AR-DEGs), and “Small Molecule Biochemis-
try” (237 AR-DEGs). The top “Physiological System
Development and Function” subcategories of IPA repre-
sented by AR-DEGs from this contrast were related to
the digestive and hepatic systems, embryonic and organ-
ismal development, and organ morphology. The top five
up-regulated genes in this contrast were IGFBP2, ADSL,
CYP3A7, CYP4A22 and BHMT; whereas, the top five
down-regulated genes were THRSPA, ME1, SCD,
LGALS1 and PLIN2, these lipogenic genes were
expressed higher in liver of the D4REFED48h chicks.
The subcellular distribution of 97 AR-DEGs control-
ling the hepatic concentration of lipid from the
D2FAST48h vs. D4REFED48h contrast is presented in
Fig. 9. Fifteen nuclear TFs (8 up-regulated in the
D2FAST48h group and 7 expressed higher in
D4REFED48h chicks) control hepatic lipid concentration
via their own interactions and with interactions with 82
AR-DEGs that are found across the cytoplasm, cell
membrane and extracellular space (Additional file 6).
Genes with red symbols are expressed higher in liver of
D2FAST48h chicks, whereas green-colored gene sym-
bols indicate higher expression in liver of D4REFED48h
chicks. Ingenuity predicts inhibition of the concentration
of lipid in the D2FAST48h vs. D4REFED48h contrast, as
expected from the D2FAST48h/D4REFED48h expres-
sion ratios. The dashed blue lines indicate AR-DEGs that
are predicted by IPA to inhibit lipid concentration, while
yellow dashed lines indicate an inconsistent finding ac-
cording to IPA’s expected expression of downstream
genes. Up-regulated cytoplasmic genes (red symbols),
expressed at higher levels in liver of D2FAST48h chicks,
are associated with lipolysis (LPL, CIDEA), beta-
oxidation (ACADL, EHHADH), glycolysis (SIRT5) and
synthesis of cholesterol (CYP3A7) and phospholipids
(AGPAT4, MOGAT1). On the other hand, several cyto-
plasmic genes expressed higher in the D4REFED48h
treatment, are involved in lipid metabolism (SCD,
INSIG1, ACAT2, HMGCR, FABP2, ELOVL5). Type 2
deiodinase (DIO2) controls generation of metabolically-
active T3, which drives activity of THRSPA, the major
lipogenic transcription factor in the chicken. Additional
genes found in the plasma membrane (ADIPOR2, PLIN2,
LPCAT3, FADS2) or extracellular space (LIPG,
ANGPTL3, ANGPTL4) that support lipid metabolism
are also expressed at higher levels in liver of
D4REFED48h chicks.
A gene interaction network functionally annotated by
IPA as “Lipid Metabolism” and “Molecular Transport”
was centered on the interactions of four upstream regu-
lators identified in the D2FAST48h vs. D4REFED48h
contrast (Fig. 10a). Four transcription factors [Jun proto-
oncogene, AP-1 transcription factor subunit (JUN), basic
leucine zipper ATF-like transcription factor 3 (BATF3),
activating signal co-integrator 1 complex subunit 1
(ASCC1), and activating transcription factor 3 (ATF3)]
were expressed higher in liver of D4REFED48h chicks.
In contrast, two transcription factors were up-regulated
in this contrast [retinoid X receptor gamma (RXRG) and
nuclear receptor subfamily 0 group B member 1
(NR0B1; a dominant-negative regulator of transcrip-
tion)]. The transcription factor JUN directly interacts
with six down-regulated AR-DEGs [ASCC1, fatty acid
binding protein 7 (FABP7), TDG, BATF3, acetyl-CoA
acetyltransferase 2 (ACAT2)] and three down-regulated
AR-DEGs [5′-aminolevulinate synthase 1 (ALAS1), sol-
ute carrier family 6 member 6 (SLC6A6) and catechol-
O-methyltransferase (COMT)]. RXRG and the RXR com-
plex were up-regulated and interact with the downregu-
lated FABP complex, which includes FABP2 and FABP7,
(See figure on previous page.)
Fig. 7 This “Lipid Metabolism” network (Panel a) is centered on interactions of three transcription factors, thyroid hormone-responsive Spot14
protein (THRSP), sterol response element binding factor 2 (SREBF2) and nuclear factor, erythroid 2-like 2 (NFE2L2) and their direct target genes
from the D2FAST48h vs. D2REFED4h contrast. IPA predicted activation (orange lines and arrows) or inhibition (blue lines) of direct targets of
SREBF2 identified in the D2FAST48h vs. D2REFED4h contrast (Panel b). Of the 22 direct target genes identified, only six AR-DEGs were expressed
at higher levels in liver of D2FAST48h chicks. As such, Ingenuity predicts that SREBF2 should be inhibited (blue symbol), which would lead to
inhibition (blue arrows/edges) of 16 DEGs (green symbols) that control lipogenesis under the direction of the most highly-expressed gene in liver
of fed or refed cockerels— the lipogenic transcription factor THRSPA
Cogburn et al. BMC Genomics          (2020) 21:109 Page 17 of 34
Fig. 8 (See legend on next page.)
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(See figure on previous page.)
Fig. 8 A gene interaction network was identified in the D2FAST48h vs. D3RERFED24h contrast and functionally annotated by IPA as related to
“Nutritional Disease” (Panel a). This gene network was centered on the interaction of the glucocorticoid receptor (NR3C1) and 16 direct target
genes, including several components of the innate immune response/ inflammation (IL15, IL1RAP, TLR5 and HERPUD1) and regulators of lipolysis
(SERTAD2 and CIDEA); all of which were highly expressed in liver of D2FAST48h chicks. Panel b shows another gene network related to “Lipid
Metabolism” that involves the transcription factor forkhead 1 (FOX01) and its 16 direct targets that interact, via ALDOB, with three ATPases and
glutathione transferases (GSTA2, MGST3 and HPGDS). The majority of the genes in this network are expressed higher in liver of D3REFED24h
chicks, except FOX01, GRHPR, SLC25A20, IDO2, ALDOB and SLC25A25, which are up-regulated by the D2FAST48h treatment
Table 5 IPA summary of liver transcriptomes in hatchling chicks-D2FAST48h vs. D4REFED48h contrasta
Top Canonical Pathways p-value Overlap Ratio
Super-pathway of Cholesterol Biosynthesis 7.68E-10 39.3% 11/28
Tryptophan Degradation III 3.74E-09 40.0% 10/25
Sirtuin Signaling Pathway 6.93E-08 10.3% 30/292
Cholesterol Biosynthesis I-II 6.99E-08 53.8% 7/13
LPS/IL-1 Mediated Inhibition of RXR Function 5.58E-07 10.8% 24/222






Top Molecular and Cellular Functions p-value # Genes
Lipid Metabolism 1.23E-03 - 6.04E-16 181
Molecular Transport 1.28E-03 - 6.04E-16 190
Small Molecule Biochemistry 1.28E-03 - 6.04E-16 237
Vitamin and Mineral Metabolism 1.14E-03 - 5.30E-14 64
Amino Acid Metabolism 1.14E-03 - 3.22E-10 38
Physiological System Development and Function p-value # Genes
Digestive System Development and Function 1.14E-03 - 6.09E-09 87
Hepatic System Development and Function 1.14E-03 - 6.09E-09 67
Organ Morphology 7.07E-04 - 6.09E-09 46
Organismal Development 1.22E-03 - 6.09E-09 147
Embryonic Development 1.22E-03 - 3.24E-08 55
Up-regulated genes FAST48h/REFED48h Down-regulated genes FAST48h/REFED48h
IGFBP2 3.31 THRSPA −6.47
ADSL 3.21 ME1 −4.97
CYP3A7 2.51 SCD −4.55
CYP4A22 2.39 LGALS2 −4.14
BHMT 2.34 PLIN2 −3.64
AIF1L 2.31 FADS2 −3.86
LDHB 2.16 CYP51A1 −3.56
ABCG5 2.06 DIO2 −2.71
NDRG1 2.04 ENOVL6 −2.59
AKR1D1 1.97 MSMO1 −2.58
aIngenuity Pathway Analysis (IPA) was used for functional analysis of 750 “Analysis Ready” (AR)-DEGs from the D2FAST48h vs. D4REFED48h contrast. The top 10
up-regulated and down-regulated AR-DEGs are presented along with their respective log2 ratio of treatment conditions, where positive numbers indicate higher
expression in the D2FAST48h treatment and negative values indicate higher expression in the D4REFED48h treatment condition
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phosphoenolpyruvate carboxykinase 1 (PCK1 or
PEPCK), ANGPTL4 and PLIN2, also down-regulated.
Two direct target genes of the RXR complex [ATP bind-
ing cassette subfamily B member 11 (ABCB11) and
CYP3A4] were up-regulated, while two additional up-
regulated monoxygenases (CYP2Q6 and CYP3A7) and
the down-regulated CYP51A1 were indirect members of
this network.
The gene network shown in Fig. 10b was functionally
annotated as “Hematological System” and composed of
three components: the transcription factor NFE2L2 and
its target genes, five up-regulated coagulation factors
[macrophage stimulating 1 (MST1), coagulation factor
II, thrombin (F2), coagulation factor IX (F9), coagulation
factor XI (F11), protein C, inactivator of coagulation
factors Va and VIIIa (PROC), protein Z, vitamin K
dependent plasma glycoprotein (PROZ) and serpin fam-
ily C member 1 (SERPINC1; or anti-thrombin 3, AT3)]
and six glutathione enzymes. Five direct targets of
NFE2L2 were up-regulated in this contrast [aldo-keto re-
ductase family 7 member A2 (AKR7A2), superoxide dis-
mutase (SOD2), microsomal glutathione S-transferase 1
(MGST1), NAD(P)H quinone dehydrogenase 1 (NQO1),
solute carrier family 16 member 2 (SLC16A2; a thyroid
hormone carrier protein)], while three target AR-DEGs
were down-regulated [MSMO1, neurensin 1 (NRSN1)
and aldo-keto reductase family 1 member A1
(ARK1A1)]. Other members of the glutathione enzyme
complex include peroxiredoxin 6 (PRDX6), glutathione
S-transferase zeta 1 (GSTZ1), glutathione S-transferase
Fig. 9 Subcellular distribution of 97 AR-DEGs functionally annotated by IPA as “Concentration of Lipids” from the D2FED48h vs. D4REFED48h
contrast. This figure provides an overview of the transcriptional hierarchy of hepatic genes that control the concentration of lipids, which was
revealed by the D2FAST48h vs. D4REFED48h contrast. Genes with red symbols are expressed higher in liver of D2FAST48h cockerels, while green
symbols indicate higher hepatic expression in the D4REFED48h treatment. A relatively small group of 15 upstream regulators control transcription
of numerous metabolic enzymes, transporters, kinases and phosphatases in the cytoplasm, several transmembrane receptors, G-protein-coupled
receptors, peptidases and enzymes in the plasma membrane, and even fewer numbers of growth factors, transporters and enzymes in
extracellular space. IPA predicts that the concentration of lipid in liver would be inhibited by the eight up-regulated transcription factors as
indicated by the dashed blue lines, while yellow dashed lines represent inconsistence between the expected state and observed of the
downstream genes. The annotated list of these 97 AR-DEGs controlling concentration of lipid is provided in Additional file 6
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pi 1 (GSTP1), microsomal glutathione S-transferase 3
(MGST3), glutathione S-transferase alpha 2 (GSTA2), N-
myristoyltransferase 2 (NMT2), phosphoribosyl pyro-
phosphate synthetase 2 (PRPS2) and G protein-coupled
receptor class C group 5 member C (GPRC5C; or retin-
oic acid-inducible gene 3, RAIG3).
Quantitative reverse transcription PCR (qRT-PCR) analysis:
verification of differential gene expression of 16
candidate genes
The independent measurement of gene expression of
eight lipogenic genes by qRT-PCR analysis is presented
in Fig. 11. The expression of these metabolic genes was
greatly depressed by fasting for 4, 24 or 48 h and re-
stored after refeeding (4, 24 or 48 h), whereas only
PPARG exhibited a progressive increase in hepatic ex-
pression with age in the fed state. Although not a meta-
bolic gene per se, argonaute 1 (AGO1), which is involved
in RNA silencing, had the same expression pattern as
the three transcription factors and four metabolic en-
zymes presented in this figure. The ANOVA showed a
significant (P ≤ 0.001) treatment effect (fed, fasted or
refed) for each of these 8 “candidate” genes. Five of these
lipogenic genes showed a significant (P ≤ 0.05) treatment
x age interaction (THRSPA, ME1, SCD, PPARG and
ANGTPL4). Furthermore, a log10-scale difference in ex-
pression was found for six genes (THRSPA, FASN, ME1,
SCD, PPARG and ANGTPL4).
The next figure (Fig. 12) presents the qRT-PCR ana-
lysis of 8 “lipolytic” genes whose expression responds to
either fasting (ALDOB, IL15, LDHB, LIPIN2, PANK1,
PPARA and UPP2) or refeeding after a 48 h fast
(INSIG2). The only gene to present a log10-scale differ-
ence in expression was UPP2. ANOVA showed that all
eight genes had significant main effects of treatment
(FED, FAST, REFED) and age (D0-D4), while only four
genes (ALDOB, IL15, INSIG1 and LDHB) showed a sig-
nificant treatment X age interaction. Three genes dem-
onstrated a clear progressive increase in expression with
age in the feed state (INSIG2, PPARA and UPP2).
Our qRT-PCR analysis also included four additional
genes that were not shown in Fig. 11 and Fig. 12 (Add-
itional file 7). FAT atypical cadherin 1 (FAT1) and
glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
were determined as DEGs by both microarray and qRT-
PCR analyses (Panel a). FAT1 expression was higher in
the fed state, depressed by fasting and restored with
refeeding. FAT1 is a tumor suppressor and involved in
WNT signaling. Both FAT1 and GAPDH showed a pro-
gressive increase with age in the fed state, both were de-
pressed in the fasted state and recovered on D4 after
being refed for 48 h. GAPDH was originally included in
qRT-PCR analysis as potential invariant gene; however,
GAPDH was rejected for normalization by the geNorm
software. Two invariant genes (Panel b), cytochrome c
oxidase subunit 7A2 like (COX7A2L) and ribosomal pro-
tein L14 (RPL14), were used by geNorm software for
normalization of qRT-PCR expression levels of candi-
date genes.
A Pearson’s Correlation Analysis was made of the
transcriptional responses of 11 candidate genes as deter-
mined by microarray and qRT-PCR analyses (Add-
itional file 8). Since the statistical analysis of microarray
data was based on normalized differential log2 expres-
sion ratios from pair-wise contrast of fasting and refeed-
ing conditions, normalized expression levels established
by qRT-PCR analysis were used to create appropriate
pairwise log2 ratios for comparison across seven treat-
ment conditions. The only candidate that failed to show
a positive correlation between microarray and qRT-PCR
analysis was insulin induced gene 1 (INSIG1), which was
not included in the Pearson’s Correlation Analysis. The
Pearson’s Correlation Analysis was completed for 11
candidate genes and the resultant Pearson’s Correlation
coefficient was used to verify differential gene expression
from two analytical methods. The average Pearson coef-
ficient across the 11 candidate genes was r = 0.970,
which indicates a highly significant (P ≤ 0.001) correl-
ation between gene expression levels obtained from
microarray and qRT-PCR analyses. Unfortunately, two
important lipid metabolism genes, FASN (RIGG07906
oligo) and PPARA (RIGG05780 oligo), appeared quite
variable in the present microarray study and, there-
fore, were not identified as DEGs by statistical ana-
lysis, although qRT-PCR analysis did reveal them as
DEGs.
(See figure on previous page.)
Fig. 10 A gene network depicting interactions among six transcription factors (JUN, RXR, NR0B1, AFT3, BATF3 and ASCC1) and their target genes
identified from the D2FAST48h vs. D4REFED48h contrast (Panel a). Nine genes in this network, annotated by IPA as “Lipid Metabolism/Molecular
Transport”, were expressed higher in liver of chicks under the D2FAST48h treatment, while 15 genes were expressed at higher levels in the
D4REFED48h chicks. Ingenuity Up-stream Regulator Analysis (Panel b) predicts that Jun proto-oncogene, AP-1 transcription factor subunit (JUN)
would be inhibited (blue gene symbol) and that seven of the 33 direct targets of JUN would be inhibited (blue arrows and green gene symbols),
whereas only two target genes [5′-aminolevulinate synthase 1 (ALAS1) and myelin basic protein (MBP)] were predicted to be actively inhibited by
JUN (blunt orange line). Another ligand-activated transcription factor, thyroid hormone-receptor beta (THRB), forms heterodimers with retinoid X
receptor gamma (RXRG). Although not an AR-DEG itself, Ingenuity predicts that THRB would be inhibited which would lead to inhibition of six
direct target genes (CTNNB1, ME1, PCK1, PPPCA, THRSPA and YWHAE), while two target genes (EGFR and EHHADH) would be actively blocked
(blunt orange edge)
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Discussion
The present transcriptional analysis of liver in newly-
hatched chicks during a fasting-refeeding perturbation
provides new insight into transcriptional control over ro-
bust homeorhetic adjustments made during the switch
from lipolysis to lipogenesis. When provided with high-
carbohydrate protein-enriched feed, the hatchling chick
is able to double its body weight in a mere 4 days (see
Fig. 1). Although newly-hatched chicks can survive for
several days without feed by utilizing lipids from the
absorbed yolk sac, prolonged fasting for the first 48 h
post-hatching prevents recovery of body weight gain,
even after 2 days after refeeding (D4). Pathway and func-
tional analyses of hepatic DEGs have identified several
major transcription factors that are interconnected and
interdependent. These transcription factors appear to
Fig. 11 Verification of differential expression of eight lipogenic genes using qRT-PCR analysis. Nutritional state is indicated by bar color, where
green = fed state, red = fasted, and blue = refed conditions. Values represent least-square means (LSM) and their standard error (LSE) of
normalized expression levels of five cockerels (biological replicates) and two technical replicates. Expression levels, determined by qRT-PCR
analysis, were normalized using the geNorm procedure in qBase software [59]. Values possessing different superscripts are significantly different
as determined by analysis of variance (ANOVA) using the general linear models (GLM) procedure in Statistical Analysis System (SAS) software and
with mean separation using Tukey’s Studentized Range Test
Cogburn et al. BMC Genomics          (2020) 21:109 Page 23 of 34
provide dynamic homeorhetic control over energy me-
tabolism during the switch in metabolism from lipolysis
to lipogenesis, as we have shown here during the switch
from fasted to refed states in newly-hatch chicks.
Transcriptional regulation of metabolism during the
fasting-refeeding perturbation
Our initial visual examination of hepatic gene expres-
sion using hierarchical and K-means clustering clearly
shows two distinct patterns, where expression of a
large group of lipogenic genes was depressed by fast-
ing and quickly restored after refeeding, or remained
high in the fully-fed state. Another group of largely
lipolytic genes showed the opposite pattern with high-
est abundance during fasting and lowest expression
after refeeding. This opposing pattern of gene expres-
sion suggests a mechanism of reciprocal inhibition of
lipolytic and lipogenic genes by the predominant tran-
scription factors controlling either metabolic state, as
discussed below.
Fig. 12 Verification of differential expression of eight lipolytic genes using qRT-PCR analysis. Nutritional state is indicated by bar color, where green = fed,
red = fasted and blue = refed condition. Values represent least-square means (LSM) and their standard error (LSE) of normalized expression of five cockerels
(biological replicates) analyzed in duplicate. Expression levels, determined by qRT-PCR analysis, were normalized using the geNorm procedure in qBase
software [59]. Values possessing different superscripts are significantly different as determined by analysis of variance (ANOVA) using the general linear
models (GLM) procedure in Statistical Analysis System (SAS) software and with mean separation using Tukey’s Studentized Range Test
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Functional and gene network analyses of AR-DEGs,
derived from multiple pair-wise contrasts of fasting-
refeeding conditions, revealed several major transcrip-
tion factors in liver that respond strongly to the meta-
bolic perturbation of fasting and re-feeding. Our study
shows that THRSPA appears to be a principal regulator
of multiple lipogenic genes (SCD, ME1, FASN, FADS2,
PLIN2, ELOVL6, MSMO1, NSDHL and INSIG1)
expressed in adipose tissue [13–15]. And, as we have re-
cently shown in liver of late embryos and hatchling
chicks during the natural perturbation of hatching,
THRSPA is also the key transcriptional regulator of the
switch in metabolism from ectothermy to endothermy
[5]. This genome-wide study of liver transcriptomes in
newly hatched chicks has also identified THRSPA as the
most abundant lipogenic transcription factor expressed.
Furthermore, we have identified several additional DEGs
(i.e., SREBF2, PPARG, PPARA, JUN, FOX01, CTNNB1,
NR3C1, SERTAD2, SIRT3 and SIRT5) that contribute to
the metabolic switch from fasting (lipolysis) to refed
(lipogenesis) states. These transcription factors can be
functionally divided into two groups lipolytic (PPARA,
NR3C1, SERTAD2, SIRT3, SIRT5, RXR, NROB1 and
FOX01) and lipogenic (THRSPA, SREBF2, PPARG,
CTNNB1 and JUN). Apparently, a handful (5–15) of key
transcription factors regulates a larger number (100) of
downstream genes involved in the synthesis or concen-
tration of lipid in liver of newly-hatched chicks.
In mammals, the THRSP gene is highly expressed in
lipogenic tissue (liver, fat, mammary gland, ovary) and
regulated by several hormones and metabolic factors
with common response elements in its promotor region
(ChoRE, SRE, LXRE and PPRE), hormone-activated nu-
clear receptors (THRB, RXR, LXR, VDR, ESR, and GCR),
and other transcription factors (SREBF2, PPARG,
PPARA, HNF4A, CREBP2, and ChREBP). Interestingly,
insulin deprivation in fed chickens depresses hepatic ex-
pression of THRSPA, ERG1, PPARG, DIO2, GK and
FASN [16]. Furthermore, the insulin-induced gene 1
(INSIG1) was highly expressed in liver of our fed and
refed hatchling chicks. In mammals, INSIG1 is a known
regulator of lipid metabolism [17]. Presently, THRSPA
and DIO2 were the highest expressed hepatic genes in
the D1FED24h vs. D1FAST24h contrast (see Table 3).
Therefore, generation of metabolically-active T3 from
enhanced DIO2 activity and co-expression of THRB
could support enhanced THRSPA expression, since its
promotor contains three synergistic thyroid hormone re-
sponse elements (TRE) [18], activated by the ligand-
bound heterodimer THRB-RXR. Furthermore, paralogs
of THRSP [THRSPΑ, THRSPΒ; Spot 14 (S14); THRSP-
like, (THRSPL) or MIG12 or S14R)] share common re-
sponse elements (RE) in their promotor regions and
have overlapping roles in regulating lipogenesis [19] and
lipid metabolism. For example, the heterodimer S14-
S14R is considered a strong ‘metabolic inhibitor’ of hu-
man acetyl-CoA carboxylase 2 (ACACA) [20], which
catalyzes the rate-limiting step in biosynthesis of fatty
acids. Specifically, the S14-S14R heterodimer exerts a
double action by preventing dimerization of ACACA
isoforms and by blocking catalytic activity of the
ACACA enzyme [20]. Thus, some actions of THRSPA
on lipogenesis in chickens are likely mediated by dimers
of THRSP paralogs. However, the exact mechanism(s)
by which THRSPA affects the expression or activity of
other transcription factors or downstream metabolic
genes in the chicken remains unclear. Further investiga-
tion will be required for elucidation of the exact mecha-
nisms by which THRSPA promotes lipogenesis and for
acknowledgement of THRSPA as the key lipogenic tran-
scription factor regulating lipid metabolism in the
chicken.
Upstream regulators of the metabolic switch from
lipolysis (fast) to lipogenesis (refed; fed)
The pair-wise contrasts made across 10 nutritional con-
ditions proved useful in detecting the hierarchy of tran-
scriptional control over responses of hundreds of
downstream DEGs involved in the homeorhetic shift
from lipolytic to lipogenic metabolism. Many ligand-
activated nuclear factors interact with THRSPA and
other transcription factors in control of expression of
their gene targets, which facilitate the homeorhetic
switch from fasting to refeeding in newly-hatched chicks.
During prolonged fasting, increased hepatic sirtuins
(SIRT1, SIRT5) and SERTAD2 stimulate lipolysis, gly-
colysis and gluconeogenesis via enhanced expression of
numerous genes, including CPT1A, NR1H4, PDK4,
PPARGC1A and ADIPOQ, as we found during the
embryo-to-hatchling transition [5] and presently during
a bout of fasting and refeeding in D0-D4 hatchlings. The
deacetylase SIRT5 regulates glycolysis and β-oxidation of
fatty acids [21], while SERTAD2 also controls lipolysis,
oxidative metabolism and thermogenesis [22–24]. We
recently discovered SERTAD2 as a novel co-regulator of
lipid catabolism, highly expressed in liver of E16 and
E18 embryos, with known interactions with other lipo-
genic transcription factors (PPARA, PPARGC1A, SIRT1
and NR1H4) [5]. For example, NR1H4 [or farnesoid X
receptor (FXR)] is a ligand-activated TF, which regulates
hepatic bile acid synthesis, while the co-regulator
PPARGC1A interacts with other transcription factors
(PPARA, PPARG, and THRSPA). The glucocorticoid re-
ceptor (GCR; or NR3C1) was also highly expressed dur-
ing prolonged fasting; NR3C1 interacts negatively and
positively with multiple transcription factors (THRSPA,
SREBF2, PPARA, PPARD, and SERTAD2) and their
downstream target genes to promote lipolysis and
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gluconeogenesis, while inhibiting lipogenic and adipo-
genic pathways. Our present example of homeorhetic
control over lipid metabolism in newly hatched chickens
is supported by the inverse (reciprocal) relationship
found between hepatic expression of LXR and THRSPA
in hatched chicks vs. week-old fed chicks [10]. The ex-
pression of LXR was reduced in D7 fed chicks, whereas
the expression of lipogenic transcription factors
(THRSPA, SREBP2 and ChREBP) and five lipogenic en-
zymes (SCD, ME1, FASN, ACACA and ACLY) was much
greater in liver of fed one-week-old chicks. Further, LXR
is a binding partner with RXR, while RXR forms hetero-
dimers with other ligand-activated nuclear factors
(THRB and PPARG), all of which bind to their respect-
ive REs on the THRSP promotor. The chicken xeno-
biotic receptor (CXR) is closely related to PXR and CAR
orthologs in mammals [25] and is capable of constitu-
tively activating expression of THRSP. The ability of
RXR to form homeodimers and heterodimers with sev-
eral nuclear receptors has prompted the view that RXR
acts as a ‘promiscuous’ regulator of nuclear receptors
[26, 27].
We found higher expression of corticotropin-releasing
hormone receptor 2 (CRHR2) in liver of D2FAST48h
chicks. Exogenous CRH in hatchling chicks enhances ex-
pression of β-oxidation enzymes to support thermogen-
esis [28]. Other transcription factors that are highly
expressed during fasting, include NR0B1 (a dominant-
negative regulator of RXR), RXR, FOXO1 (a promotor of
insulin signaling [29]), and NFE2L2 (a negative regulator
of fatty acid synthesis) [30]. In our present study, the ex-
pression of FOXO1 was highest with prolonged fasting
and showed direct actions with many lipid metabolism
enzymes (see Fig. 8). In mammals, NFE2L2 is a suppres-
sor of adipocyte lipolysis [31]; our study revealed direct
interaction of NFE2L2 with SREBF2 and THRSPA in
regulating lipid metabolism (see Fig. 8), while NFE2L2
was central to a gene interaction network (Fig. 10b) in-
volving glutathione metabolism and the up-regulation of
multiple hemostatic factors (F2, F9, F11, PROC, PROZ
and SERPINC1) in liver of the D2FAST48h chicks when
compared to D4REFED48h chicks.
In the present study, the adipokine RARRES2 was up-
regulated by prolonged fasting (see Figs. 5 and 7) and
regarded as a direct target of SREBF2. We first identified
chemerin or RARRES2 as a novel chicken adipokine that
was highly expressed in abdominal fat of lean line (LL)
chickens rather than fat line (FL) chickens [13]. In con-
trast, RARRES2 serves as a biomarker of obesity and
metabolic syndrome in humans [32–34]. Other adipo-
kines (or hepatokines) that were expressed higher in
liver of fully-fed or refed chicks included angiopoietin-
like protein 3 (ANGPTL3) and angiopoietin-like protein
4 (ANGPTL4), which inhibit plasma lipoprotein lipase
(LPL) and therefore clearance of triglycerides and
phospholipids.
After hatching and consuming its first carbohydrate
and protein rich meal, a small number of transcription
factors appear to activate lipogenic, adipogenic and
thermogenic pathways, which were strongly depressed in
embryos. And as emphasized in the transcriptional ana-
lysis of liver from newly-hatched (D0) and fed D7 chicks,
the hepatic lipogenic program is likely activated by both
endocrine and nutrient signals once the chick consumes
carbohydrate-rich feed and purges residual yolk lipids
[10]. Major lipogenic genes were up-regulated in liver of
fed chicks (THRSPA, SREBP2, SCD, ME1, FASN, ACLY,
ACACA, PLIN2, INSIG1 and DHCR24), whereas delayed
feeding for 48 h post-hatch dampens initial up-
regulation of these key lipogenic genes. Many of the
same transcription factors identified presently by pro-
longed fasting-refeeding of newly hatched chicks (D0-
D4) were also differentially expressed in liver of embryos
compared to hatchling chicks [5]. This observation sug-
gests that a common reciprocal homeorhetic mechanism
controls metabolic adjustments during the embryo-to-
hatchling transition or an episode of fasting and refeed-
ing in hatchlings; both perturbations activate the switch
from lipid catabolism (embryo) to lipogenesis/thermo-
genesis (hatchling).
Another hepatic gene that was highly expressed in the
D4REFED48h chicks was DHCR24, an insulin induced
gene that catalyzes the final step in cholesterol biosyn-
thesis. A recent RNA-seq analysis of liver and adipose
tissue in chickens has provided avian biologists an exten-
sive functional catalog with co-expression profiles of
mRNA and long-non-coding RNAs (lncRNA) [35]. Of
particular interest, DHCR24 and lncRNA_DHCR24 are
positively correlated and both co-expressed at high levels
in liver of 9-wk-old cockerels that had been fasted for
12 h and then refed for 3 h before sampling [35]. The
possibility of bidirectional promoters and lncRNA_
DHCR24 regulation of DHCR24 expression and ultim-
ately cholesterol synthesis, adds a new dimension to the
complexity of transcriptional control over lipid metabol-
ism in the chicken. Certainly, microRNAs are involved
in the robust homeorhetic control of energy metabolism
induced by fasting and refeeding in newly-hatched
chicks. This was well demonstrated in a recent paper de-
scribing microRNAs in liver of E18-E20 embryos and
D0-D3 hatchlings that target key lipid metabolic genes,
including ADIPOR2, ELOVL6, FASN, ME1, SCD,
MSMO1, FADS1, FADS2, INSIG2 and HMGCS1 [6, 36].
The reciprocal expression pattern exhibited by several
key lipogenic genes and the targeting microRNAs is in-
triguing and likely involved in fine tuning of metabolic
responses to fasting and refeeding perturbations, as we
have presently described in D0-D4 hatchling chicks. The
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same metabolic genes were also DEGs found in our
transcription analysis of the embryo-to-hatchling transi-
tion [5] and presently in fed, fasted or refed D1-D4
chicks. An earlier transcriptional analysis of liver in
broiler chicks at hatch (D0) and at D7, after D2 fasted
chicks were refed on D2, clearly shows THRSPA and
SREBP2 are the prominent up-regulated transcription
factors, which could control higher expression of many
lipogenic enzymes (i.e., ME1, FASN, SCD, ACAC and
ACYL) at 1 week of age (D7) [10].
Presently, our gene interaction networks show
THRSPA as the ultimate transcription factor controlling
lipogenesis in the newly-hatched chicken. The THRSP
promoter is driven by multiple response elements, in-
cluding three synergetic-acting TREs [18], ChoRE [37,
38], SRE and LXRE [39], and a RXR response element
[40], although RA-activated RXR forms heterodimers
with ligand-activated THRB and LXRA to promote ac-
tion of their respective response elements. The liver acti-
vated receptors (LXR-α,-β) are regulators of adipocyte
gene expression; and they form heterodimers with other
nuclear hormone receptors (LXR-RXR, RXR-THRB) to
control lipid metabolism as directed by THRSP, a ‘LXR-
responsive gene’ in addition to being glucose- and
insulin-responsive [41] and A proven master regulator of
lipogenesis and adipogenesis. A polyunsaturated fatty
acids response region (PUFA-RR) in the rat THRSP pro-
motor inhibits THRSP transcription [42]. The PUFA in-
hibition of THRSP (S14) is mediated by SREBP1a
binding to the PUFA-RR within the promoter of the rat
S14 gene [43]. In the rat, PPARA also blocks THRSP ex-
pression by interfering with THRB-T3 binding to the
multiple TREs in the THRSP promoter, rather than via a
PPARA response element (PPAR-RE) [44]. These nutri-
ent- and hormone-activated elements are also found in
promotors of five major lipogenic enzymes (SCD, ME1,
FASN, ACACA, and ACYL), see Fig. 3 in [10]. The
higher expression of ChREBP is interesting since
THRSPA transcription parallels the enhanced SREBP2
and ChREBP transcription in liver of D7 chicks; and ex-
pression of THRSPA itself is activated by a ChoRE
within its promotor. These studies further support our
long-held idea that THRSPA is the principal transcrip-
tion factor that regulates lipogenesis during an abrupt
switch from lipolytic to lipogenic metabolism. Thus,
multiple response elements activated or inhibited by nu-
clear factors and metabolites control expression of the
lipogenic and adipogenic THRSP paralogs and subse-
quently lipid synthesis.
In chicken liver, miR-107 targets FASN mRNA while
other miRNAs target other lipogenic genes, including
SCD, FADS2, LPIN1, ACACA, ACOX1, MSMO1,
ELOVL1, ELOVL2, ELOVL5, INSIG1, HMGCS1 and
HMGCR [6, 36]. Another miRNA, miR-128-3p, inhibits
adipogenesis by targeting PPARA and SERTAD2, which
results in blocked differentiation of preadipocytes and
enhanced lipolysis, respectively [45]. Furthermore, MiR-
451a directly targets THRSP and downstream lipogenic
enzymes, which reduces lipogenesis and adipogenesis in
mammalian models [46]. From these examples, it seems
obvious that micro-RNAs and lncRNAs contribute to fine
tuning of yin-and-yang adjustments in lipid metabolism.
Our present study of fasting and refeeding in newly-
hatched chicks has provided ample evidence of homeor-
hetic responses driven by interconnectivity and inter-
dependence exhibited by a few transcriptional regulators
(THRSPA, SREBF2, PPARA and PPARG) and their nu-
merous downstream lipolytic versus lipogenic genes.
Many of these transcriptional regulators and miRNA-
targeted lipolytic and lipogenic genes were identified in
our recent contrasts of liver transcriptomes in embryos
versus hatchling chicks [5].
Conclusions
Our analyses of liver transcriptome during a fasting-
refeeding perturbation immediately after hatching shows
that THRSPA functions as the ultimate transcriptional
regulator of lipogenesis and thermogenesis in the
chicken. Our present integration of transcriptional pro-
filing of liver in newly-hatched chicks during a fasting
and re-feeding episode has revealed several
differentially-expressed upstream regulators. These tran-
scription factors are interactive and interdependent,
which provides the homeorhetic mechanisms driven by
reciprocal actions and interactions of nuclear factors that
activate or inhibit response elements in promotors of
other transcription factors. Interactions of few transcrip-
tion factors and their more numerous target genes en-
able the switch in metabolism from a fasting (lipolytic/
gluconeogenic) state to the refed or fully-fed (lipogenic/
thermogenic) state. This rapid homeorhetic shift of
whole-body metabolism from a catabolic fasting state to
the fed/refed anabolic state appears precisely orches-
trated by a small number of ligand-activated transcrip-
tion factors. These hepatic transcription factors favor
either a fasting lipolytic state (PPARA, NR3C1, FOX01,
NFE2L2, SERTAD2, NR0B1 and RXR) or the fed lipo-
genic state (THRSPA, SREBF2, PPARG, PPARD,
CTNNB1 and JUN). These upstream regulators control
of a variety of downstream genes encoding: metabolic
enzymes, transporters, acute-phase response proteins,
and clotting/immune factors. Several signaling factors
were mapped to canonical metabolic and regulatory
pathways (i.e., lipid metabolism, gluconeogenesis and
glycolysis, growth factor signaling, and immune defense).
Clearly, THRSPA has emerged as the predominant lipo-
genic and thermogenic transcription factor and most re-
sponsive gene found in liver of newly-hatched (D0-D4)
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chicks in the fed or refed state. Furthermore, the dimin-
ished growth that follows prolonged (48 h) fasting of
newly-hatched chicks also illustrates the importance of
early placement of day-old broiler chicks on feed (and
water), before they deplete retained yolk lipids.
Methods
Experimental design
A randomized block design was used to administer 10
treatment conditions (T1-T10), each containing five bio-
logical samples (5 cockerels), and taken during a bout of
fasting and re-feeding in newly-hatched (D0-D4) broiler
cockerels (Fig. 13.) Several experimental designs and
statistical analyses (e.g., K-Means Clustering in Fig. 1)
were used in the following sections and described
accordingly.
Experimental chickens
Fertile eggs (Ross x Ross breed) were obtained from a
commercial hatchery (Allen’s Hatchery, Seaford DE) and
incubated in the Animal Facility, Department of Animal
and Avian Sciences, University of Maryland (College
Park, MD). The same experimental design was used earl-
ier for our transcriptional and pathway analysis of the
hypothalamus during a fasting and refeeding perturb-
ation of newly-hatched (D0-D4) chicks [8]. Briefly, fertile
eggs were incubated under standard conditions (37.5 °C
and 60% relative humidity) with automatic rotation every
hour and transferred to a hatching incubator on
embryonic day 18 (E18), where E0 is defined as the start
of incubation. All chicks (N = 50) used in this experi-
ment were hatched within a 3–4-h period on E21 (D0)
and given free access to water. After hatching (D0)
chicks were randomly assigned to ten treatment groups,
namely T1-T10 (Fig. 13). Only male chicks (cockerels)
were used prevent confounding effects of sex. At hatch-
ing, control fed groups (T2, T4, T7 and T9; n = 20) were
immediately provided ad libitum with water and a com-
mercial starter ration until the time of tissue sampling
on D1, D2, D3 and D4, respectively. After hatching,
chicks in the T1, T3 and T5 groups (N = 15) were
brooded with water freely available, but without access
to feed (i.e., prolong-fasting) for 4, 24 and 48 h, respect-
ively. Chicks in the T6, T8 and T10 groups (N = 15)
were fasted for 48 h and subsequently re-fed for 4, 24
and 48 h, respectively, prior to tissue sampling. Male sex
was visually verified upon visceral dissection and collec-
tion of liver samples. After collection of a 2 ml blood
sample and euthanasia by cervical dislocation, liver sam-
ples were quickly excised, immediately snap frozen in li-
quid nitrogen, and then stored at − 80 °C until total
RNA isolation for microarray and qRT-PCR analyses.
Plasma samples were analyzed in duplicate for metabol-
ite levels (glucose, non-esterified fatty acids (NEFA), and
triglycerides). The care, maintenance and experimental
use of hatchling chicks (Gallus gallus) were performed
in accordance with the United States Department of
Agriculture (USDA) guidelines on the Use of
Fig. 13 Experimental design of the fasting and re-feeding perturbation in newly-hatched broiler chicks. Five newly-hatched male chicks were
randomly assigned to 10 treatment groups (T1-T10). The chicks assigned to control fully-fed groups (D1FED24h or T2, D2FED48h or T4, D3FED72h
or T7, and D4FED96h or T9) were provided with a commercial starter ration and water ad libitum from hatching (D0) until the time of tissue
sampling. Fasting groups (D0FAST4h or T1, D1FAST24h or T3, and D2FAST48h or T5) of chicks were brooded with no access to feed (start after
hatchling) for 4, 24 and 48 h, respectively. Chicks in the REFED groups (D2REFED4h or T6, D3REFED24h or T8 and D4REFED48h or T10) were
fasted for 48 h and subsequently re-fed for 4, 24 and 48 h, respectively, prior to the time of tissue sampling
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Agricultural Animals in Research and approved by the
University of Maryland and the University of Delaware
Agricultural Animal Care and Use Committees (AACU
C).
Plasma glucose, non-esterified fatty acid (NEFA) and
triglyceride assays
Circulating glucose, NEFA and triglyceride concentra-
tions were determined in duplicate from plasma col-
lected from five individual birds per treatment group
(N = 50). Samples were stored at − 20 °C until the metab-
olite assays. Plasma glucose levels were determined using
Autokit Glucose reagents (Wako Chemicals Richmond,
VA) according to the manufacturer’s instructions.
Plasma NEFA levels were determined using the Wako
NEFA HR kit and triglyceride concentrations were de-
termined using a L-Type TG H (Wako Chemicals Rich-
mond, VA) following the assay kit’s instructions. All
assays were optimized for microtiter plates and per-
formed in a SpectraMax 190 microtiter plate reader
(Molecular Devices, Sunnyvale, CA).
Microarray analysis
Chicken long oligo microarrays
Fifty microarray slides printed with 20,676 (20.7 K)
chicken oligonucleotides (oligo) were obtained from the
Genomics Research Laboratory at the Steele Children’s
Research Center at the University of Arizona (http://
www.grl.steelecenter.arizona.edu/products.asp). Chicken
long oligos (70-mers) for this genome-wide microarray
were originally designed by ARK-Genomics (http://www.
ark-genomics.org/microarrays/bySpecies/chicken/) from
chicken ENSEMBL transcripts. The chicken oligo set
[Gallus gallus (chicken) Roslin/ARK CoRe Array V1.0]
was manufactured by Operon Technologies, Inc. The de-
tailed description of the “Arizona” 20.7 K chicken oligo
microarray is available at NCBI GEO (Platform
GPL6049). The detailed annotation file of oligos printed
on this microarray was obtained from European Animal
Disease Genomics Network of Excellence (EADGENE)
project [47]. Automated annotation of differentially-
expressed oligo targets on the Arizona 20.7 K array was
achieved using the “Oligo Arrays” function on our la-
boratory website (http://cogburn.dbi.udel.edu/index.
html).
RNA isolation and dye labeling
Total RNA from frozen liver samples was isolated using
an RNeasy Midi kit (Qiagen, Valencia, CA) following the
manufacturer’s protocol. The quantity of total RNA was
determined using a NanoDrop spectrophotometer (Wil-
mington, DE), and RNA quality was examined by micro-
capillary electrophoresis with a BioAnalyzer 2100
(Agilent, Wilmington, DE). RNA amplification was
performed with an Amino Allyl MessageAmp™ II aRNA
Amplification Kit according to manufacturer’s instruc-
tion (Ambion, Austin, TX). A single round of RNA amp-
lification was conducted with 4 μg of total RNA. In vitro
transcription (IVT) of amino allyl-modified aRNA was
performed for 14 h at 37 °C. The integrity of aRNA was
determined by a BioAnalyzer using the RNA 6000 Nano
Assay kit and the concentration of aRNA with a Nano-
Drop ND-1000 spectrophotometer prior to the aRNA-
dye coupling reaction. The dye labeling was performed
according to the instructions for dye coupling and la-
beled aRNA cleanup with the Amino Allyl Messa-
geAmp™ II aRNA Amplification kit. Briefly, twenty
micrograms of aRNA was dried down in a SpeedVac
concentrator, reconstituted in 9 μl of coupling buffer
and mixed with 11 μl of prepared fluorescent dyes (60 μg
aliquot of either Alexa 555 or Alexa 647 dissolved in
DMSO). The coupling reaction took place in the dark
for 1 hour at room temperature. Purified labeled aRNA
was determined for concentration and dye incorporation
using a NanoDrop and dye incorporation efficiency was
calculated with a web tool (www.ambion.com/tools/dye).
The balanced-block hybridization design used for the 50
oligo arrays used in the present study is provided in
Additional file 9.
Hybridization and scanning of microarrays
The chicken oligo microarrays were baked at 90 °C for
90 min prior to use. The slides were pre-treated for 45
min at 42 °C in pre-hybridization solution (5x SSC, 0.1%
SDS and 1% BSA) and followed by dipping in 2x SSC for
5 min and then in 0.2x SSC for 5 min. The slides were
dried by centrifugation (5 min at 1000 x g). An aliquot
of five micrograms of purified labeled aRNA samples
was fragmented in 1x fragmentation buffer (Ambion,
Austin, TX) for 15 min at 70 °C. The reaction was then
terminated by adding stop solution and dried down in a
SpeedVac. Each fragmented aRNA sample was reconsti-
tuted in 30 μl of pre-warmed DIG Easy Hyb solution
(Roche Diagnostics Corporation, Indianapolis, IN). All
reference aRNA samples within the same hybridization
day were pooled together, equally divided in 30 μl ali-
quots and co-hybridized with each target sample on a
slide. The target and reference aRNA samples were
mixed with 2.5 μl of 10 mg/ml yeast tRNA and 2.5 μl of
10 mg/ml salmon testes DNA (Sigma, Louis, MO). The
reference/target mixture (65 μl) was denatured for 2 min
at 94 °C, cooled at room temperature, carefully loaded
onto the middle of a pre-treated slide held in a
hybridization chamber (Corning #2551, Lowell, MA) and
overlaid with a 22 × 65mm glass coverslip (LifterSlip;
Erie Scientific, Portsmouth, NH). The sealed
hybridization chambers were incubated overnight (14–
16 h) at 42 °C in a water bath covered with a light-tight
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box. On the following day, the cover slips were flushed
off in wash solution #1 (1x SSC, 0.2% SDS, and 0.5%
DTT) and slides were sequentially washed with pre-
warmed wash solution #1 at 42 °C for 10 min, then
washed in solution #2 (0.1 x SSC, 0.2% SDS, and 0.5%
DTT) for 5 min at room temperature, and finally washed
in solution #3 (0.1 x SSC and 0.5% DTT) for 1 min at
room temperature. The slides were subsequently rinsed
in MilliQ-purified water and dried by centrifugation.
The slides were stored in individual 50 ml tubes covered
in aluminum foil and flooded with pure nitrogen gas
until scanning. For each slide, a high-resolution TIFF
image file was generated using a GenePix 4000B micro-
array scanner and analyzed with GenePix Pro V4.1 soft-
ware (Axon Laboratories, Palo Alto, CA). The TIFF
images were acquired at 10 μm resolution by simultan-
eous scanning at two wavelengths [532 nm (Alexa 555)
and 635 nm (Alexa 647)]. The PMT count ratio (635/
532) was adjusted to 1 during preview at low resolution
scanning. All slides were manually checked for quality
and all spots with inadequacies in signal, background or
morphology were eliminated. The image analysis results
were merged with Excel files (in GPR format) containing
clone identification, spot location on slide, and most
current gene annotation based on BLASTN or BLASTX
score. The GPR files from the 50 microarray scans were
then used for normalization and statistical analysis to
determine differential gene expression.
Normalization and statistical analysis of microarray data
The processing, normalization and determination of dif-
ferential gene expression was completed using the Linear
Models for Microarrays (LIMMA) program [48], as pre-
viously described for a reference RNA hybridization de-
sign [49]. Briefly, log2 transformed median intensity
values for each dye (Alexa Flour™ 555 or Alexa Flour™
647) were normalized using a LOWESS transformation
[50], without background correction [51, 52]. The
Benjamini-Hochberg procedure [53] was used to control
experiment-wise false discovery rate (FDR ≤ 0.05) associ-
ated with multiple testing (FDR adjusted P ≤ 0.05). Gene
expression represents the log2 of normalized dye ratios
(sample aRNA-green/reference aRNA-red). The log2 FC
was further scaled to have the same median-absolute de-
viation [54]. As described earlier [49], the LIMMA out-
put was statistically analyzed using a linear mixed model
in SAS (Statistical Analysis System, Cary NC). Mixed
models in SAS [55, 56] were used to account for bio-
logical and technical variation (dye, day of hybridization)
across the 50 oligo microarrays and to determine differ-
ential expression of a gene possessing a FDR-adjusted p-
value (P ≤ 0.05). Forty-five pairwise contrasts were made
across the 10 treatment conditions, where gene expres-
sion values represent the log2 fold-change (FC) [57] of
treatment contrasts (e.g., T4/T5 or D2FED48h/
D2FAST48h). Four pairwise contrasts (C1 = T2/T3;
C2 = T4/T5; C3 = T5/T6; C4 = T5/T8) were used for K-
means cluster analysis to identify clusters of
functionally-related genes (see Fig. 13; Additional file 1).
Lists of differentially-expressed genes (DEGs) from pair-
wise contrasts were initially annotated using the “Oligo
Arrays” function on our laboratory website [58], which
was specifically designed for the horizontally-printed
Arizona 20.7 K Chicken Oligo Array (NCBI GEO Plat-
form GPL6049). Finally, lists of DEGs from each con-
trast were used as input for Ingenuity Pathway Analysis
and further functional annotation. This minimum infor-
mation about a microarray experiment (MIAME)-com-
pliant dataset was deposited in the NCBI GEO database
under accession number GSE9745.
Hierarchical cluster analysis
A preliminary hierarchical cluster analysis of DEGs was
conducted using GeneSpring GX software (Agilent
Technologies, Santa Clara, CA) to initially visualize dif-
ferences in gene expression patterns across 50 chick liver
transcriptomes during an episode of fasting and refeed-
ing (D0-D4). This dataset was used to generate a heat
map of differentially expressed gene (DEG) across the
first 4 days of life and under the metabolic perturbation
of fasting and refeeding (10 treatment conditions). This
dataset from unsupervised hierarchical clustering was
only used for preliminary visual analysis of gene expres-
sion patterns during fasting and refeeding (see Fig. 2a).
K-means cluster analysis
K-means clustering was used for visualization of gene
expression patterns in response to fasted vs. refeed con-
ditions (see Fig. 2b; Additional file 1). Treatment con-
trasts (C1-C4) represent log2 ratios of four pair-wise
comparisons [C1 = D1FED vs. D1FAST24h, C2 = D2FED
vs. D2FAST48h, C3 = D2FAST48h vs. D3REFED4h, and
C4 = D2FAST48 vs. D3REFED24h]. Contrasts C1 and
C2 have positive or negative log2 fold-change (FC)
values, which represent down-regulation or up-
regulation by fasting, respectively. Likewise, FC for con-
trasts C3 and C4 indicate either down-regulation or up-
regulation due to re-feeding for 4 h or 24 h (after a 48 h
fast), respectively. These log2 FC values were multiplied
by − 1 to make the relative expression (log2 FC) either
positive for up-regulation or negative for down-
regulation of gene expression.
Functional analysis of DEGs using ingenuity pathway
analysis (IPA)
Ingenuity® Pathway Analysis (IPA) was used for func-
tional annotation and mapping of DEGs to canonical
pathways, biological processes and gene interaction
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networks. IPA Fisher’s Exact Test is used by IPA to test
for significance (P ≤ 0.05) and over-representation of
DEGs in canonical pathways and biological processes.
The DEGs accepted by IPA are considered as “Analysis
Ready” (AR)-DEGs, if the gene is curated and annotated
in the Ingenuity® Knowledge Base, which is mainly cu-
rated from the mammalian biomedical literature and de-
void of many avian-specific genes. A combination of the
chicken gene symbol (primary gene ID) and the NCBI
RefSeq Protein ID (secondary gene ID) was used to
maximize the number of chicken genes DEGs accepted
by IPA as AR-DEGs. However, almost a quarter of DEGs
with a chicken-specific RefSeq Protein ID were rejected
by IPA software (see Additional file 2). The Ingenuity®
Upstream Regulator Analysis within IPA was used to
identify major transcription factors and to predict either
activation or inhibition of direct target genes by their
upstream regulators.
Quantitative reverse transcription-PCR (qRT-PCR) analysis
and verification of DEGs
An aliquot of each total RNA sample from the 50 liver
samples (10 treatments with 5 biological replicates per
treatment) was used for qRT-PCR analysis to verify dif-
ferential gene expression. Sixteen differentially-expressed
genes (DEGs) identified by microarray analysis, were
used for qRT-PCR analysis, plus an additional four “in-
variant” genes that were used for normalization of qRT-
PCR expression levels (Additional file 10). Selection of
the 16 “candidate” genes was based on prior knowledge
of their involvement in lipid metabolism. In additional, a
panel of four invariant genes (ATPCL, COX7A2L,
GAPDH and PRL14) was included in the qRT-PCR ana-
lysis for normalization of qRT-PCR expression. First-
strand cDNA was synthesized using 1 μg of total RNA,
oligo-dT, random hexamer primers and SuperScript III
reverse transcriptase kit (Invitrogen Life Technologies,
Carlsbad CA). Primers used for qPCR were designed
using Primer Express (Applied Biosystems, Foster City,
CA). The qRT-PCR assay was performed for each sam-
ple in duplicate wells using Power SYBR green PCR
master mix (Applied Biosystems, Foster City, CA) and a
gene-specific primer-pair (Sigma-Genosys, Woodlands,
TX) on an ABI Prism Sequence Detection System
7900HT. Biogazelle qbase+ software [59] was used for
pre-processing of raw cycle threshold (Ct) data and the
geNorm procedure was used for normalization of rela-
tive gene expression levels. The expression stability of
candidate genes and a panel of invariant “housekeeping”
genes was based on the geNorm (M) and coefficient of
variation (CV) values across duplicate measurements of
the 50 liver RNA samples. Ribosomal protein L14
(RPL14) and cytochrome c oxidase subunit VIIa poly-
peptide 2-like (COX7A2L) were selected as optimal co-
reference genes. The PROC GLM in Statistical Analysis
System (SAS, v.9.4; Cary NC) was used to analyze differ-
ences among the 10 treatment groups and control for
multiple comparisons using the option ADJUST =
TUKEY. The Pearson’s correlation function in Excel was
used to compare normalized expression levels of “candi-
date” DEGs identified by microarray analysis with nor-
malized qRT-PCR expression levels.
Supplementary information
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Additional file 1: K-means clusters identified from four pairwise
contrasts of fasting and refeeding conditions. A Microsoft Excel file
containing two worksheets named: “K-means clusters_FDR adj P≤0.05”
and “Plots of K-Means Clusters (C0-C9)”. The first worksheet provides an
annotated list of the 196 DEGs assigned to 10 clusters (C0-C9) of
functionally-related hepatic genes. Information is provided on each DEG
including the RIGG oligo ID, gene symbol, gene description, log2 fold-
change (FC) of pairwise contrasts of fasting (C1 and C2) and refeeding
(C3 and C4) conditions, and the cluster number. The second worksheet
contains a PowerPoint figure composed of 10 K-Means Clusters that dif-
ferentially respond to fasting and refeeding conditions.
Additional file 2: Comparison of DEGs identified by microarray analysis
versus “Analysis Ready” (AR)-DEGs accepted by IPA. A Microsoft Excel file
containing a single worksheet “ IPA rejection of DEGs”. This worksheet list
the number of chicken DEGs (FDR adj. P ≤ 0.05) identified by microarray
analysis and the number of “Analysis Ready” (AR)-DEGs recognized by the
Ingenuity Knowledge Base and used for Ingenuity Pathway Analysis (IPA).
On average, 22.5% of the chicken microarray DEGs identified with a valid
RefSeq ID were rejected by IPA.
Additional file 3: Lists of DEGs from five meaningful pairwise contrasts
of fasting and refeeding conditions. A Microsoft Excel file containing five
worksheets of AR-DEGs (FDR adjusted P ≤ 0.05) identified from pairwise
contrasts. Each worksheet provides a list of AR-DEGs identified by pair-
wise treatment contrasts including the gene symbol, Entrez gene name,
log2 expression ratio, and gene/protein ID number.
Additional file 4: Over-represented canonical and functional pathways
identified by IPA in the D2FED48h vs D2FAST48h contrast. A Microsoft
Excel file containing eight worksheets of AR-DEGs (FDR adjusted P ≤ 0.05)
mapped to over-represented canonical and functional pathways. Each
worksheet provides the gene symbol, Entrez gene name, log2 ratio, cellu-
lar location and type of gene.
Additional file 5: Over-represented canonical and functional pathways
identified by IPA in the D2FAST48h vs D3REFED24h contrast. A Microsoft
Excel file containing eight worksheets of AR-DEGs (FDR adjusted P ≤ 0.05)
mapped by IPA to over-represented canonical and functional pathways.
Each worksheet provides the gene symbol, Entrez gene name, log2 ratio,
cellular location and type of gene.
Additional file 6: Over-represented canonical and functional pathways
identified by IPA in the D2FAST48h vs D4REFED48h contrast. A Microsoft
Excel file containing eight worksheets of AR-DEGs (FDR adjusted P ≤ 0.05)
mapped to over-represented canonical and functional pathways. Each
worksheet provides the gene symbol, Entrez gene name, log2 ratio, cellu-
lar location and type of gene.
Additional file 7: Four additional genes used for qRT-PCR analysis. A
PowerPoint figure showing qRT-PCR analysis of two candidate genes
[FAT atypical cadherin 1 (FAT1); glyceraldehyde-3-phosphate dehydrogen-
ase (GAPDH)] and two invariant genes [cytochrome c oxidase subunit
7A2 like (COX7A2L); ribosomal protein L14 (RPL14)]. Both COX7A2L and
RPL14 were used by geNorm software for normalization of gene expres-
sion as determined by qRT-PCR analysis. Nutritional state is indicated by
bar color, where green = fed, red = fasted, and blue = refed conditions.
Values represent least-square means (LSM) and their standard error (LSE)
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of normalized expression levels of five cockerels (biological replicates) an-
alyzed in duplicate. Expression levels, determined by qRT-PCR analysis,
were normalized using the geNorm procedure in qBase software [59].
Values possessing different superscripts are significantly different as deter-
mined by analysis of variance (ANOVA) using the general linear models
(GLM) procedure in Statistical Analysis System (SAS) software and with
mean separation using Tukey’s Studentized Range Test.
Additional file 8: Pearson’s Correlation Analysis of gene expression
levels of 10 DEGs determined by genome microarray and verified by qRT-
PCR analyses. A Microsoft Excel file containing the average normalized ex-
pression level (log2 ratio) of 10 DEGs as determined by both microarray
analysis and qRT-PCR analysis. The Pearson’s correlation coefficient (r =
0.970; P ≤ 0.01, 8 degrees of freedom) indicates a highly significant correl-
ation between gene expression levels obtained from both microarray
and qRT-PCR analyses.
Additional file 9: Microarray reference RNA hybridization design. A
Microsoft Excel file containing a single worksheet “20.7 K Array
Hybridization Design”. A total of 50 Arizona 20.7 K Chicken Oligo Arrays
(NCBI GEO Platform # GPL6049) were used in a reference RNA
hybridization design. Each biological sample (liver RNA sample) was
labelled with Alexa Flour® 555 (green) dye. An aliquot of the pooled
reference RNA sample was labelled with Alexa Flour® 647 (red) dye and
these were hybridized together on one of the 20.7 K oligo microarrays.
The 50 microarrays were assigned to 10 fasting-refeeding treatment
groups with five biological replicates (liver RNA from five cockerels). A
balanced block design was used for hybridization of 10 microarrays
across 5 consecutive days, where one liver RNA sample represented each
of the 10 treatment groups on each hybridization day (10 arrays/day).
Additional file 10: Information on primers used for qRT-PCR verification
of differential gene expression. A Microsoft Excel file containing a single
worksheet “Primers qRT-PCR Assay”. This table provides information on
the design of qRT-PCR primers for 20 chicken genes. The Roslin Institute
Gallus gallus (RIGG) oligo ID number, NCBI Entrez Gene ID, gene symbol,
gene description, and the 5′-3′ sequence for forward and reverse primers
used for qRT-PCR analysis are provided. Although four “invariant genes”
were included, only two genes were acceptable by qBase software for
use in normalization of qRT-PCR expression levels.
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ACSL5: Acyl-CoA synthetase long chain family member 5;
ADIPOR2: Adiponectin receptor 2; AGO1: Argonaute 1; ANGPTL3: Angiopoietin
like 3; ANOVA: Analysis-of-variance; ATF4: Activating transcription factor 4a;
CREB2: cAMP-response element binding protein 2; Ct: Average cycle time;
CTNNB1: Catenin beta 1; D0-D4: Age, Day 0-Day 4; DEGs: Differentially-
expressed genes; DHCR7: 7-dehydrocholesterol reductase; DIO2: Type 2
deiodinase; F11: Coagulation factor XI; F2: Coagulation factor II, thrombin;
F9: Coagulation factor IX; FADS2: Fatty acid desaturase 2; FC: Fold change;
FDR: False discovery rate; FKBP5: FK506 binding protein 5;
GCR: Glucocorticoid receptor; GEO: Gene Expression Omnibus; GLM: General
linear model; IGFBP2: Insulin-like growth factor binding protein 2;
IPA: Ingenuity Pathway Analysis; JUN: Jun proto-oncogene, AP-1 transcription
factor subunit; LIMMA: Linear Models for Microarrays; lncRNA: Long non-
coding RNA; LSD: Least significant difference; ME1: Malic enzyme 1;
MIAME: Minimum information about a microarray experiment;
miRNA: microRNA; MST1: Macrophage stimulating 1; MUSTN1: Embryonic
nuclear protein 1; NCBI: National Center for Biotechnology Information;
PANK1: Pantothenate kinase 1; PROC: Protein C, inactivator of coagulation
factors Va and VIIIa; PROZ: Protein Z, vitamin K dependent plasma
glycoprotein; qRT-PCR: Quantitative reverse transcriptase polymerase chain
reaction; RARRES2: Retinoic acid receptor responder 2; RIN: RNA integrity
number; RNA: Amplified RNA; RXR: Retinoid X receptor; SAS: Statistical
Analysis System; SERPINC1: Serpin family C member 1; SERTAD2: SERTA
domain containing 2; SIRT1: Sirtuin 1; SIRT5: Sirtuin 5; THRSPA: Thyroid
hormone-responsive Spot 14 protein, alpha; UPP2: Uridine phosphorylase 2
Acknowledgements
We gratefully acknowledged the contribution of several undergraduates and
graduate students, post-doctoral fellows and technical staff from both institu-
tions (University of Delaware and University of Maryland) toward completion
of this collaborative project. The authors are also thankful to Professor Robert
J. Tempelman (Michigan State University) for processing and statistical ana-
lysis of this microarray dataset, K-means cluster analysis, and for making mul-
tiple pairwise contrasts of fasting and refeeding conditions.
Authors’ contributions
LAC and TEP secured funding. LAC, TEP, and LEE designed and performed
the animal experiment. NT isolated RNA from the liver samples, labeled,
hybridized and scanned the 50 Arizona Chicken 20.7 K Oligo Arrays. NT
conducted the qRT-PCR analysis, completed statistical analysis of the qRT-
PCR dataset. The processing, normalization and statistical analyses of the 50
microarrays were completed as fee-for-service by Robert J. Tempelman
(Michigan State University, East Lansing, Mich.). NT submitted the MIAME-
compliant data files to NCBI GEO. Also NT completed qRT-PCR analysis and
statistical analysis of phenotypic and qRT-PCR expression data. LAC com-
pleted the Ingenuity Pathway Analysis (IPA) of the microarray AR-DEG con-
trasts and, with XW, completed the first draft of the manuscript. All
coauthors (LAC, NT, XW, LEE and TEP) reviewed, revised, commented on, and
approved the final version of the manuscript.
Funding
This research was supported by the United States Department of Agriculture,
Cooperative State Research, Education, and Extension Service, Initiative for
Future Agriculture and Food Systems (USDA-CREES-IFAFS) Grant 00–52,100–
9614 to LAC and TEP; and the USDA-National Research Initiative (NRI) #2005–
35206-15288 to LAC and TEP. The funding agency provided funding for the
research projects, but had no role in the design of the experiment, statistical
analysis, interpretation of the data, nor writing of the manuscript. Publication
cost was kindly provided by the Department of Animal and Food Sciences,
University of Delaware.
Availability of data and materials
The files containing minimum information about a microarray experiment
(MIAME)-compliant microarray experiment are available from the NCBI GEO
database under accession number GSE9745. Additional data generated or
analyzed during this study are included within this published article and
supplementary files. Multiple worksheets in Additional file 3 provide lists of
DEGs found in four meaningful pair-wise contrasts of fed, fasted and refed
chicks from statistical analysis of the microarray data.
Ethics approval and consent to participate
The care, maintenance and experimental use of hatchling chicks (Gallus
gallus) were performed in accordance with the United States Department of
Agriculture (USDA) guidelines on the use of agricultural animals in research
and approved by the University of Maryland and the University of Delaware




The authors declare that they have no competing interests.
Author details
1Department of Animal and Food Sciences, University of Delaware, Newark,
DE 19717, USA. 2Leibniz Institute for Farm Animal Biology, Institute for
Genome Biology, Wilhelm-Stahl-Allee 2, 18196 Dummerstorf, DE, Germany.
3Department of Biological Sciences, Tennessee State University, Nashville, TN
37209, USA. 4Department of Poultry Science, University of Georgia, Athens,
GA 30602, USA. 5Department of Avian and Animal Sciences, University of
Maryland, College Park, MD 20742, USA.
Received: 1 May 2019 Accepted: 22 January 2020
References
1. Cogburn LA, Wang X, Carré W, Rejto L, Porter TE, Aggrey SE, Simon J.
Systems-wide chicken DNA microarrays, gene expression profiling and
discovery of functional genes. Poult Sci. 2003;82:939–51.
2. Cogburn LA, Morgan R, Burnside J. Expressed sequence tags, DNA chip
technology and gene expression profiling. In: Muir WM, Aggrey SE, editors.
Cogburn et al. BMC Genomics          (2020) 21:109 Page 32 of 34
Poultry Genetics, Breeding and Biotechnology. Wallingford: CABI Publishing;
2003. p. 629–46.
3. Cogburn LA, Wang X, Carré W, Rejto L, Aggrey SE, Duclos MJ, Simon J,
Porter TE. Functional genomics in chickens: development of integrated-
systems microarrays for transcriptional profiling and discovery of regulatory
pathways. Comp Funct Genom. 2004;5:253–61.
4. Cogburn LA, Porter TE, Duclos MJ, Simon J, Burgess SC, Zhu JJ, Cheng HH,
Dodgson JB, Burnside J. Functional genomics of the chicken--a model
organism. Poult Sci. 2007;86:2059–94.
5. Cogburn LA, Trakooljul N, Chen C, Huang H, Wu CH, Carré W, Wang X,
White HB. Transcriptional profiling of liver during the critical embryo-to-
hatchling transition period in the chicken (Gallus gallus). BMC Genomics.
2018;19:695.
6. Hicks JA, Porter TE, Liu HC. Identification of microRNAs controlling hepatic
mRNA levels for metabolic genes during the metabolic transition from
embryonic to posthatch development in the chicken. BMC Genomics. 2017;
18:687.
7. Desert C, Duclos M, Blavy P, Lecerf F, Moreews F, Klopp C, Aubry M, Herault
F, Le Roy P, Berri C, Douaire M, Diot C, Lagarrigue S. Transcriptome profiling
of the feeding-to-fasting transition in chicken liver. BMC Genomics. 2008;9:
611.
8. Higgins SE, Ellestad LE, Trakooljul N, McCarthy F, Saliba J, Cogburn LA,
Porter TE. Transcriptional and pathway analysis in the hypothalamus of
newly hatched chicks during fasting and delayed feeding. BMC Genomics.
2010;11:162.
9. Fang X-L, Zhu X-T, Chen S-F, Zhang Z-Q, Zeng Q-J, Deng L, Peng J-L, Yu J-J,
Wang L-N, Wang S-B, Gao P, Jiang Q-Y, Shu G. Differential gene expression
pattern in hypothalamus of chickens during fasting-induced metabolic
reprogramming: functions of glucose and lipid metabolism in the feed
intake of chickens. Poult Sci. 2014;93:2841–54.
10. Richards MP, Proszkowiec-Weglarz M, Rosebrough RW, McMurtry JP, Angel
R. Effects of early neonatal development and delayed feeding immediately
post-hatch on the hepatic lipogenic program in broiler chicks. Comp
Biochem Physiol B. 2010;157:374–88.
11. Payne JA, Proszkowiec-Weglarz M, Ellestad LE. Delayed access to feed alters
expression of genes associated with carbohydrate and amino acid
utilization in newly hatched broiler chicks. Am J Physiol-Regul Integr Comp
Physiol. 2019;317:R864–78.
12. Casel P, Moreews F, Lagarrigue S. Klopp C: sigReannot: an oligo-set re-
annotation pipeline based on similarities with the Ensembl transcripts and
Unigene clusters. BMC Proc. 2009;3:S3.
13. Resnyk CW, Carré W, Wang X, Porter TE, Simon J, Le Bihan-Duval E, Duclos
MJ, Aggrey SE, Cogburn LA. Transcriptional analysis of abdominal fat in
genetically fat and lean chickens reveals adipokines, lipogenic genes and a
link between hemostasis and leanness. BMC Genomics. 2013;14:557.
14. Resnyk CW, Chen C, Huang H, Wu CH, Simon J, Le Bihan-Duval E, Duclos
MJ, Cogburn LA. RNA-Seq analysis of abdominal fat in genetically fat and
lean chickens highlights a divergence in expression of genes controlling
adiposity, hemostasis, and lipid metabolism. PLoS One. 2015;10:e0139549.
15. Resnyk CW, Carré W, Wang X, Porter TE, Simon J, Le Bihan-Duval E, Duclos
MJ, Aggrey SE, Cogburn LA. Transcriptional analysis of abdominal fat in
chickens divergently selected on bodyweight at two ages reveals novel
mechanisms controlling adiposity: validating visceral adipose tissue as a
dynamic endocrine and metabolic organ. BMC Genomics. 2017;18:626.
16. Dupont J, Tesseraud S, Derouet M, Collin A, Rideau N, Crochet S, Godet E,
Cailleau-Audouin E, Metayer-Coustard S, Duclos MJ, Gespach C, Porter TE,
Cogburn LA, Simon J. Insulin immuno-neutralization in chicken: effects on
insulin signaling and gene expression in liver and muscle. J Endocrnol.
2008;197:531–42.
17. Dong XY, Tang SQ. Insulin-induced gene: a new regulator in lipid
metabolism. Peptides. 2010;31:2145–50.
18. Liu HC, Towle HC. Functional synergism between multiple thyroid hormone
response elements regulates hepatic expression of the rat S14 gene. Mol
Endocrinol. 1994;8:1021–37.
19. Aipoalani DL, O'Callaghan BL, Mashek DG, Mariash CN, Towle HC.
Overlapping roles of the glucose-responsive genes, S14 and S14R, in
hepatic lipogenesis. Endocrinology. 2010;151:2071–7.
20. Park S, Hwang IW, Makishima Y, Perales-Clemente E, Kato T, Niederländer NJ,
Park EY, Terzic A. Spot14/Mig12 heterocomplex sequesters polymerization
and restrains catalytic function of human acetyl-CoA carboxylase 2. J Mol
Recognit. 2013;2013, 679(/11/11):–688.
21. Kumar S, Lombard DB. Functions of the sirtuin deacylase SIRT5 in normal
physiology and pathobiology. Crit Rev Biochem Mol Biol. 2018;53:311–34.
22. Liew CW, Boucher J, Cheong JK, Vernochet C, Koh HJ, Mallol C, Townsend K,
Langin D, Kawamori D, Hu J, Tseng YH, Hellerstein MK, Farmer SR, Goodyear
L, Doria A, Blüher M, Hsu SIH, Kulkarni RN. Ablation of TRIP-Br2, a regulator
of fat lipolysis, thermogenesis and oxidative metabolism, prevents diet-
induced obesity and insulin resistance. Nat Med. 2013;19:217.
23. Qiang G, Kong HW, Fang D, McCann M, Yang X, Du G, Blüher M, Zhu J,
Liew CW. The obesity-induced transcriptional regulator TRIP-Br2 mediates
visceral fat endoplasmic reticulum stress-induced inflammation. Nat
Commun. 2016;7:11378.
24. Qiang G, Kong HW, Gil V, Liew CW. Transcription regulator TRIP-Br2 mediates
ER stress-induced brown adipocytes dysfunction. Sci Rep. 2017;7:40215.
25. Handschin C, Podvinec M, Meyer UA. CXR, a chicken xenobiotic-sensing
orphan nuclear receptor, is related to both mammalian pregnane X
receptor (PXR) and constitutive androstane receptor (CAR). Proc Natl Acad
Sci U S A. 2000;97:10769.
26. Desvergne B, Michalik L, Wahli W. Transcriptional regulation of metabolism.
Physiol Rev. 2006;86:465–514.
27. Clark AK, Wilder JH, Grayson AW, Johnson QR, Lindsay RJ, Nellas RB,
Fernandez EJ, Shen T. The promiscuity of allosteric regulation of nuclear
receptors by retinoid X receptor. J Phys Chem B. 2016;25:8338–45.
28. Mujahid A, Furuse M. Central administration of corticotropin-releasing factor
induces thermogenesis by changes in mitochondrial bioenergetics in
neonatal chicks. Neuroscience. 2008;155:845–51.
29. Rajan MR, Nyman E, Brännmark C, Olofsson CS, Strölfors P. Inhibition of
FOXO1 transcription factor in primary human adipocytes mimics the insulin-
resistant state of type 2 diabetes. Biochem J. 2018;475:1807.
30. Ludtmann MHR, Angelova PR, Zhang Y, Abramov AY, Dinkova-Kostova AT.
Nrf2 affects the efficiency of mitochondrial fatty acid oxidation. Biochem J.
2014;457:415–24.
31. Li X, Cheng Y, Zhong X, Zhang B, Bao Z, Zhang Y, Wang Z. Nuclear factor
erythroid 2-related factor 2 activation mediates hyperhomocysteinemia-
associated lipolysis suppression in adipocytes. Exp Biol Med. 2018;243:926–33.
32. Goralski KB, McCarthy TC, Hanniman EA, Zabel BA, Butcher EC, Parlee SD,
Muruganandan S, Sinal CJ. Chemerin, a novel adipokine that regulates
adipogenesis and adipocyte metabolism. J Biol Chem. 2007;282:28175–88.
33. Bozaoglu K, Bolton K, McMillan J, Zimmet P, Jowett J, Collier G, Walder K,
Segal D. Chemerin is a novel adipokine associated with obesity and
metabolic syndrome. Endocrinology. 2007;148:4687–94.
34. Bozaoglu K, Segal D, Shields KA, Cummings N, Curran JE, Comuzzie AG,
Mahaney MC, Rainwater DL, VandeBerg JL, MacCluer JW, Collier G, Blangero
J, Walder K, Jowett JBM. Chemerin is associated with metabolic syndrome
phenotypes in a Mexican-American population. J Clin Endocrinol Metab.
2009;94:3085–8.
35. Muret K, Klopp C, Wucher V, Esquerré D, Legeai F, Lecerf F, Désert C, Boutin
M, Jehl F, Acloque H, Giuffra E, Djebali S, Foissac S, Derrien T, Lagarrigue S.
Long noncoding RNA repertoire in chicken liver and adipose tissue. Genet
Sel Evol. 2017;49:6.
36. Hicks JA, Trakooljul N, Liu HC. Discovery of chicken microRNAs associated
with lipogenesis and cell proliferation. Physiol Genomics. 2010;41:185–93.
37. Mariash CN, Goto Y, Sudo Y. Location of a glucose-dependent response
region in the rat S14 promoter. Endocrinology. 1993;133:1221–9.
38. Sudo Y, Mariash CN. Two glucose-signaling pathways in S14 gene
transcription in primary hepatocytes: a common role of protein
phosphorylation. Endocrinology. 1994;134:2532–40.
39. Wu J, Wang C, Li S, Li S, Wang W, Li J, Chi Y, Yang H. Kong xi, Zhou Y, Dong
C, Wang F, Xu G, Yang J, Gustafsson J, guan Y: thyroid hormone-responsive
SPOT 14 homolog promotes hepatic lipogenesis, and its expression is
regulated by liver X receptor a through a sterol regulatory element-binding
protein -1c-dependent mechanism in mice. Hepatology. 2013;58:617–28.
40. MacDougald OA, Jump DB. Localization of an adipocyte-specific retinoic
acid response domain controlling S14 gene transcription. Biochem Biophys
Res Commun. 1992;188:470–6.
41. Hummasti S, Laffitte BA, Watson MA, Galardi C, Chao LC, Ramamurthy L,
Moore JT, Tontonoz P. Liver X receptors are regulators of adipocyte gene
expression but not differentiation: identification of apoD as a direct target. J
Lipid Res. 2004;45:616–25.
42. Jump DB, Clarke SD, MacDougald O, Thelen A. Polyunsaturated fatty acids
inhibit S14 gene transcription in rat liver and cultured hepatocytes. Proc
Natl Acad Sci U S A. 1993;90:8454–8.
Cogburn et al. BMC Genomics          (2020) 21:109 Page 33 of 34
43. Mater MK, Thelen AP, Pan DA, Jump DB. Sterol response element-binding
protein 1c (SREBP1c) is involved in the polyunsaturated fatty acid
suppression of hepatic S14 gene transcription. J Biol Chem. 1999;274:
32725–32.
44. Ren B, Thelen A, Peters FJ, Jump DB. Polyunsaturated fatty acid suppression
of hepatic fatty acid synthase and S14 gene expression does not require
peroxisome proliferator-activated receptor alpha. J Biol Chem. 1997;272:
26827–32.
45. Chen C, Deng Y, Hu X, Ren H, Zhu J, Fu S, Xie J. Peng Y: miR-128-3p
regulates 3T3-L1 adipogenesis and lipolysis by targeting Pparg and Sertad2.
J Physiol Biochem. 2018.
46. Zeng N, Huang R, Li N, Jiang H, Li R, Wang F, Chen W, Xia M, Wang Q. MiR-
451a attenuates free fatty acids-mediated hepatocyte steatosis by targeting
the thyroid hormone responsive spot 14 gene. Mol Cell Endocrinol. 2018;
474:260–71.
47. Hedegaard J, Arce C, Bicciato S, Bonnet A, Buitenhuis B, Collado-Romero M,
Conley L, SanCristobal M, Ferrari F, Garrido J, Groenen M, Hornshoj H,
Hulsegge I, Jiang L, Jimenez-Marin A, Kommadath A, Lagarrigue S,
Leunissen J, Liaubet L, Neerincx P, Nie H, Poel J, Prickett D, Ramirez-Boo M,
Rebel J, Robert-Granie C, Skarman A, Smits M, Sorensen P, Tosser-Klopp G,
Watson M. Methods for interpreting lists of affected genes obtained in a
DNA microarray experiment. BMC Proc. 2009;3:S5.
48. Smyth GK. Limma: linear models for microarray data. New York: Springer;
2005. p. 397–420.
49. Cogburn LA, Smarsh DN, Wang X, Trakooljul N, Carré W. White HB3:
transcriptional profiling of liver in riboflavin-deficient chicken embryos
explains impaired lipid utilization, energy depletion, massive hemorrhaging,
and delayed feathering. BMC Genomics. 2018;19:177.
50. Yang YH, Dudoit S, Luu P, Lin DM, Peng V, Ngai J, Speed TP. Normalization
for cDNA microarray data: a robust composite method addressing single
and multiple slide systematic variation. Nucleic Acids Res. 2002;30:e15–0.
51. Allison DB, Cui X, Page GP, Sabripour M. Microarray data analysis: from
disarray to consolidation and consensus. Nat Rev Genet. 2006;7:55–65.
52. Kerr KF, Serikawa KA, Wei C, Peters MA, Bumgarner RE. What is the best
reference RNA? And othe questions regarding the design and analysis of
two-color microarray experiiments. OMICS: a J Integr Biol. 2007.
53. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical
and powerful approach to multiple testing. J Royal Stat Soc (Series B). 1995;
57:289–300.
54. Smyth GK. Linear models and empirical bayes methods for assessing
differential expression in microarray experiments. Stat Appl Genet Mol Biol.
2004;3:–Article3.
55. Rosa GJM, Steibel JP, Tempelman RJ. Reassessing design and analysis of
two-colour microarray experiments using mixed effects models. Comp
Funct Genom. 2005;6:123–31.
56. Tempelman RJ. Assessing statistical precision, power, and robustness of
alternative experimental designs for two color microarray platforms based
on mixed effects models. Vet Immunol Immunopathol. 2005;105:175–86.
57. Witten DM, Tibshirani R. A comparison of fold-change and the t-statistic for
microarray data analysis. In: Technical Report, Department of Statistics,
Stanford University, vol. 2007; 2007. p. 1–17.
58. Cogburn, LA: Cogburn Laboratory. 2017. http://cogburn.dbi.udel.edu/index.
html. Accessed 17 Dec 2017.
59. Biogazelle qbase+ software. 2016. https://www.qbaseplus.com. Accessed 15
Aug 2016.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Cogburn et al. BMC Genomics          (2020) 21:109 Page 34 of 34
